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Abstract
Whole-Genome Sequencing (WGS) is ushering a new era in healthcare and research in identifying
genetic variation in all populations. However, the African populations are still under-represented.
Since African populations are being the most genetically diverse with high heterogeneity rate,
we need to benchmark the Whole Genome Sequence (WGS) analysis pipeline to ensure reliable
mutation detection. Therefore, it is essential to ensure that all steps of WGS downstream
analysis are accurate, mainly the variant calling (VC). Current VC tools may produce false-
positive/negative results; such result may produce misleading conclusions in prioritisation of
mutation, clinical relevancy and actionability of genes. With such many VC tools, two questions
have arisen. Firstly, which tool has a high rate of sensitivity and precision in low either high
coverage African sequences, given they have high genetic diversity and heterogeneity? Secondly,
does the improvement of the VC result will advance the accuracy of detecting mutation and
incidental finding (actionable genes) in African populations?
In this project, a total of 100 DNA sequence samples was simulated (of which every 50
samples mimicked the genetics background of African and European, respectively) at different
coverage (high and low). In particular, the sensitivity to discover polymorphisms was done
by nine different VC tools. These tools were assessed in term of false positive/negative call
rate given the simulated golden variants. Combining our result on sensitivity and positive
predictive value (PPV). Lofreq performs best in African population data (sens=0.85, PPV=0.983,
F-score=0.91) on high/low coverage data; as a result, we chose Lofreq to perform variant calling,
and Gene-based annotation is performed to conduct in-sillico predication of mutation on publicly
available data (the African Genome Variation and 1000 Genome Project). In doing so, we have
leveraged WGS to examine and validate four of burden diseases in the African content, such
as communicable diseases: HIV/AIDS, Malaria, Tuberculosis (TB), and Non-communicable
diseases: such as Sickle cell disease, these diseases have uniquely shaped ethnic-specific and
continental genomics variation and therefore provides unprecedented opportunities to map
disease genes across the African continent. Moreover, the current actionable gene recommended
by The American College of Medical Genetics and Genomics (ACMG) in the African population
and update on additional African-specific actionable genes.
Our result suggests African and African diaspora ethnic groups, particularly Bantu and
Khoesan ethnics have gene diversity, high proportion of derived allele at low minor allele
frequency (0.0− 01) and the highest proportion of pathogenic variants within HIV, TB, Malaria,
Sickle-Cell disease, while non-African ethnic groups including Latin America, Afro-Asiatic
European related ethnic groups have high proportion of pathogenic variants within current
actionable gene list.
Overall, given the observed highest genetic diversity found in African ethnics and African
diaspora related ethnics at these four Africa burden diseases and current actionable gene
associated, our results support (1) the use of personalised medicine as beneficial to both African
continent and worldwide; (2) a recommendation for African-specific actionable list of genes to
further improve African and diaspora healthcare.
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”Ex Africa surgit semper aliquid novi”, it means there is always something new rises out of
Africa, this quote was written nearly 2000 years ago by the Roman scholar and a naturalist
philosopher Pliny the Elder. This quote applies perfectly to the genomics studies of the African
populations, as there are always new findings of genetic variations (Sirugo et al., 2008) from
their genomes.
These discoveries in the African genetics markedly increased alongside the massive evolvement
of the sequencing methods over the past few decades. Next-Generation Sequencing (NGS) has
allowed for a vast increase in data outputs in a shorter time with decreasing costs.
The impact of NGS on modern biological science is second to none. It is a revolution that
could be compared with the one that followed Sanger sequencing 40 years ago (Mielczarek &
Szyda, 2016). As a result, the field of application for such data has expanded; it has shed light on
the path of genomics, epigenomics, pharmacogenomics, and personalise medicine (Shen, de Stadt,
Yeat, & Lin, 2015). Furthermore, this revolution has led to understanding diseases etiology,
diagnosis, management and treatment planning for both communicable (e.g. HIV/AIDS, Malaria
and Tuberculosis) and non-communicable diseases (e.g. Sickle cell disease), and these diseases
are a burden on the African continent with the highest prevalence rate in the whole world.
Moreover, alongside with findings resulted from Whole-genome sequencing/ whole-exome
sequencing, it is a necessity to investigate and return secondary finding (Actionable genes)
as advised by The American College of Medical Genetics and Genomics (ACMG) (Green et
al., 2013). Such a development in NGS has an impact on developing the downstream analysis
tools, accordingly, increase the demands on developing deoxyribonucleic acid (DNA) sequencing
simulations tools to validate these tools. However, despite the advancement of the NGS and the
downstream analysis tools, yet the African populations are still under-represented (Retshabile et
al., 2018; Bope et al., 2019). The complex demographic history of the African populations, ethnic
diversity, migrations have altered the pattern of genetics variations, accordingly, the African
genomes harbor the highest genetics diversity alongside with low level of linkage disequilibrium
(LD) when compared to other populations (Sirugo et al., 2008; C. N. Rotimi et al., 2017; Bope
et al., 2019). Regardless of the challenges, it is important to understand and investigates this
diversity in the genomes of the African populations.
To discover these variations, we must focus on the downstream analysis step, particularly,
variant calling. Major advantage of NGS is to detect genetic variant like Single Nucleotide
Polymorphism/Variation (SNP/SNV), Insertions and Deletions (Indels), Structural Variants
(SV), e.g. Copy Number Variation/Alteration (CNV/CNA). SNPs are single base pair mutation
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that may affect nucleic acid or protein binding and activity. Hence, we can identify these
SNPs to investigate genetic alterations and then determine if these variations may be the
cause of a specific phenotype or trait condition. There are various variant calling approaches
available which use NGS data to identify SNPs (E. R. Martin et al., 2010; Durtschi, Margraf,
Coonrod, Mallempati, & Voelkerding, 2013; Lai et al., 2016; Fang et al., 2017; Pipek et al., 2017;
Sandmann, de Graaf, et al., 2017) and each approach implements a different algorithm with
different assumptions. Consequently, all do not always provide the same output (Pabinger et
al., 2014), either same SNPs discovery along the genome.
Although, NGS has developed to produce massive amount of parallelism and a huge amount
of data, with reduced sequencing time and coast, yet the downstream analysis process is still an
important bottleneck (Escalona et al., 2017). Particularly, it is challenging when dealing with
the African genomes as it has the highest genetic diversity and low level of linkage disequilibrium,
as it may lead to a high rate of false-positive/negative results (Bope et al., 2019). Most of the
current NGS downstream analysis tools have been performed and tested on European data
(Campbell & Tishkoff, 2008; Popejoy & Fullerton, 2016; A. R. Martin, Teferra, Möller, Hoal,
& Daly, 2018) known of high range of haplotypes, however to best to our knowledge, there
are no variant calling tools been tested or either designed to deal with the complexity of the
African genomes. While the world is moving toward precision medicine, it is vital to develop
bioinformatics tools includes variant calling tools with high sensitivity and precision tailored to
populations characterised by high genetic variations and low linkage disequilibrium. As a result,
these developed tools will contribute in improving the overall health care and scientific research
and most important precision medicine in Africa. Moreover, these developed tools will enhance
the diagnosis and treatment of Africa’s most common diseases such as Malaria, HIV/AIDS,
Tuberculosis (TB) and non-communicable disease such as Sickle cell disease.
Previous studies have primarily focused on detecting the best variant calling tools, such
as (Bauer & Bauer, 2011; Zook et al., 2014; Huang, Mullikin, & Hansen, 2015) and others.
Yet, to the best of our knowledge, none of these studies have focused on the African genomes.
These studies have evaluated variant calling tools on different parameters, including sensitivity
and low rate of false-positive and false-negative, etc. False-positive (FPs) may potentially
arise through the use of an inappropriate reference genome. The current reference may not be
suitable for all populations, notably for the African genomes, which are known to be very high
diverged with low level of linkage disequilibrium. Current variant calling methods have differing
advantages and disadvantages. Thus, it is imperative to evaluate these tools and determine
which method is the least error-prone on either low or high sequences coverage of the African
genomes. These concerns are shared with the consortium of The Human Heredity and Health in
Africa (H3Africa), by developing policies and guidance to return genetic feedback of findings to
improve genetic research in the African continent (H3 Africa Working Group on Ethics, 2017).
Further, the burden of communicable and non-communicable diseases in the African continent
has uniquely shaped ethnic-specific and continental genomic variation and therefore provides
unprecedented opportunities to map disease genes across the continent. As a result, it is
important to leverage the availability of genotypes and WGS data from newly and previously
studied African populations to understand the spectrum of medical and clinical implications
of genome variation from the African populations (Mpye et al., 2017). Furthermore, (Bope
et al., 2019) recommended to develop African reference panel and benchmark best variant
calling tool using African sequences. In doing so, researchers will provide better classification
of the pathogenic and actionable variants (also known as secondary/accidental finding)(Green
et al., 2013). Towards this end, our research project consists of three parts, following similar
approaches as (Sandmann, De Graaf, et al., 2017) and (Bope et al., 2019).
The overall objectives of this research is (1) to detect best variant calling tool from using
simulated DNA sequences data based on benchmarking nine state-of-the-art variant calling tools;
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(2) apply the obtained best variant calling tool to perform variant calling on 20 world-wide ethic
groups from real data (publicly available data as 1000 Genome project and the African Genome
Variation Project); (3) conduct gene-based annotation and in silico prediction of mutation using
the obtained variant callings data sets based on known associated genes of four selected disorders
of relevance to Africa, include communicable diseases (HIV/AIDS, Malaria, Tuberculosis), and
Non-communicable diseases (Sickle cell disease) and a list of current known actionable genes as
recommended by the American College of Medical Genetics (ACMG) (Green et al., 2013).
In this Chapter, previous studies regarding variant calling will be reviewed, alongside a
brief overview of the genes that associated with diseases especially, the diseases that considered
as burden in the African continent such as communicable diseases: HIV/AIDS, Malaria,
Tuberculosis (TB), and Non-communicable diseases: such as Sickle cell disease and investigating
the actionable genes.
1.2 Problem Statement
Globally, human populations show structured genetic diversity as a result of geographical
dispersion, admixture, selection and drift. Understanding this genetic variation can provide
insights from our human origins into clinical applications. In these contexts, Africa represents
the ancestral birthplace of modern humans. Populations from Africa have the highest levels of
genetic diversity and less Linkage disequilibrium (LD)
The complex history of the African populations remains a challenge to unravel based on the
present documented records of the interaction and movement among populations. Although,
there has been a remarkable growth of African genomics data, the sequencing of individuals
within Africa is limited. Critically, through the development of high-density microarrays and next-
generation sequencing technologies, the past decade has seen a considerable movement towards
the generation of high-resolution genomics data, which has contributed to the identification and
fine-mapping of complex disease loci, mostly in European populations.
Advances in high-throughput sequencing have facilitated the development of a range of
statistical genomics approaches and applications. These advances in high-throughput technolo-
gies have led to an unprecedented increase in the computational complexity of downstream
data analysis. An obstacle to validating and bench-marking methods for genome analysis
is that there are few reference data sets available for which the “ground truth” about the
mutational landscape of the sample genome is known and fully validated. Furthermore, accuracy,
effectiveness and performance assessments of different analytical methods used to analyse next
generation sequence data are important aspects of medical population genetics.
Variant calling (VC) is an important aspect of genomics studies as polymorphism information
can be used to influence important clinical decisions. However, currently most variant calling
tools have been designed to leverage populations of long-range haplotypes such as European
populations. Differences in genetic characteristics as mentioned above can significantly affect
the performance of not only the variant discovery tools, but also downstream bioinformatics
analysis tools. Another concern with variant calling is the use of inappropriate reference samples
-which leads to an increased rate of false positive (FP) and false negative (FN) SNPs. Therefore,
it is critical to detect the true and accurate mutation mainly for rare Mendelian diseases using
the Whole Genome Sequencing (WGS) analysis and furthermore secondary findings, without
mistaken it with false-positive variants or lose tracing it in false-negative results during variant
calling filtering processes. Particularly, when detecting mutations in the African genome data.
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1.3 Research Questions
Reflecting to the above problem statement in previous section, a number of questions have
arisen:
(a) Which variant calling tool has the least error pore with a high rate of sensitivity and
precision, regarding dealing with African genome?
(b) How can we prevent false-positive variants through the process of mutation identification?
(c) Does the improvement of the VC result will advance the accuracy of detecting pathogenic
mutation, actionable variants relevant to clinical applications?
1.4 Research Aims and Objectives
1.4.1 Overall hypothesis
We hypothesise that choosing the best variant calling tool, which can accurately call true variant
with high sensitivity and can handle the high variation diversity presents in the African genome.
Alongside, applying this variant calling tool on leveraging whole genome sequence of African
versus non-African will elucidate evolutionary variation in causal mutation patterns and genes
actionability to improve the spectrum of medical and clinical implications.
1.4.2 Project objective
This project aimed to:
1. To perform a join variant calling on simulated data (of which every 50 samples mimicked
the genetics background of African and European, respectively) to benchmark nine different
variant calling tool, and detecting best tool performed best on low/high coverage of African
genome data.
2. To systematically assess and identify the false-positive SNPs, from variant calling data
analysis, and to improve the mean of SNP identification. This aim will enable us to
investigate the evolutionary variation of mutation across 20 world-wide population ethic
groups.
3. To apply the best variant calling tool on publicly available data, the African Genome
Variation and 1000 Genome Project and examine the evolutionary variation of pathogenic
mutation based on selected known disease-genes from four big African burden diseases
include HIV/AIDS, Malaria, Tuberculosis (TB), Sickle cell disease and a set of known
actionable genes across 20 world-wide population ethic groups.
4. To perform disease-genes population structure from these known disease-genes (HIV/AIDS,
Malaria, Tuberculosis (TB), Sickle cell disease and a set of known actionable genes) among
20 world-wide ethnic-specific data.
5. To examine the heterozygosity ratio, the proportion of ancestral/Derived alleles, and
the distribution of minor allele frequencies based on these selected disease-genes from
HIV/AIDS, Malaria, Tuberculosis (TB), Sickle cell disease and a set of known actionable
genes across 20 world-wide ethnic-specific data.
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1.5 Dissertation Outline
In this current chapter, we continue reviewing relevant literature. This project is divided into
three important parts represented by each chapter as follow:
Chapter 2 covers the simulation of a total of 100 DNA sequence samples (of which each set
of 50 samples of low and high sequence coverage mimicked the genetics background of African
and European, respectively) at different coverage. This chpater provides also a brief overview of
current DNA sequence simulations tools and the general simulation processes.
Chapter 3, assesses and evaluates nine different state-of-the-art variant calling tools on the
African and European simulated DNA sequence data resulted from chapter 2. This chapter
illustrates the characteristics and specifications of each variant calling tools used in this project.
Furthermore, the evaluation metrics of these tools are also discussed.
Chapter 4, discusses the application of the suggested best variant calling tool as per the
obtained result from chapter 3, on WGS public data grouped into 20 different ethnics. This
chapter presents downstream analyses of the variants discovery from WGS and discusses the
secondary finding of 20 world-wide ethnics groups. Furthermore, it presents the analysis of
genetics diversity, heterozygosity ratio, proportion of ancestral/Derived alleles, and the distribu-
tion of minor allele frequencies based on sets of selected known disease-associated variants from
four top African burden diseases include HIV/AIDS, Malaria, Tuberculosis (TB), Sickle cell
disease and a set of known actionable gene in 20 world-wide ethnic population groups.
Finally, the overall discussion and conclusion are in Chapter 5.
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1.6 Overview on Next Generation Sequencing Downstream
Analysis
Next Generations Sequencing has revolutionised genetics by massive parallelisation, resulting in a
tremendous amount of short DNA fragment in a short time (Mardis, 2008; Metzker, 2010). Once
the library preparation, cluster amplification, and DNA sequencing are done, the researchers
are confronted with an enormous amount of raw data (Pabinger et al., 2014). Analysing NGS
raw data will help us to provide a molecular diagnosis of diseases, and it consists of five explicit
steps below and Figure 1.1 illustrates the overall process:
1. Quality assessment of NGS: it is the first step of ensuring that the raw FASTQ
files which are generated from the sequencing platforms are in an excellent quality prior
alignment to a reference genome. The FASTQ files that do not meet the defined standard
should either be removed, trimmed or filtered. There are various quality control tools
to assess NGS reads quality; one of these tools is FastQC (Andrews et al., 2012), which
provides diagnosis reports and summary graphs and export the results to an HTML report.
FastQC is able to calculate the Phred quality score that is distributed along with the
reads, and calculating the mean of GC content distribution, read length and duplication
level. FastQC allows detecting possible over-represented reads, which may be caused by
contamination in the primer or adopter (Bao et al., 2014).
2. Read alignment to a reference genome: It is necessary to ensure the accuracy of
the reading alignment as it plays a crucial role in identifying variations. Reads are either
aligned to a reference genome or without a reference which is known as de novo assembly.
There are numerous alignment algorithms, such as hash tables, suffix/prefix tree and
Burrows-Wheeler Transform (BWT) algorithm (H. Li & Homer, 2010). In this project
BWA alignment tool will be used, it is one of the most widely used aligner based on
suffix/prefix tree (H. Li & Durbin, 2009, 2010).
3. Variant identifications: It is one of the most important steps in the downstream
analysis; it is the process of identifying variants that are different from the reference data.
These variants may cause mutations, so it is essential to call the true positive variant by
using an accurate variant calling tool. This step is considered as a challenge since there
are many variants calling tools with different calling algorithms such as Heuristic approach
and statistical approach. There are two different variant calling tools, somatic/tumor or
germline (inherited) caller. We will expatiate on variant calling step further in much more
details in Section 1.7.
4. Annotations and Prioritising mutations: After variant calls are generated, we need
to perform mutation prediction and prioritisation to be able to understand the biological
and the functional insight within the generated data (H. Yang & Wang, 2015). Annotation
tools have been evolved to aid in filtering and prioritise different kinds of variants such
as, SNPs, Indels and CNV in-order to predict potential mutation that causes diseases
(Pabinger et al., 2014) and characterise their biological functions.
In like manner, annotations tools integrate detail and information such as minor allele
frequency (MAF), clinically significant variants, deleterious prediction of variant function to
gather more information about variants (Bao et al., 2014) from public databases,. Most studies
focus on non-synonymous SNVs, Indels in the protein-coding regions, as it is the cause of 85% of
the discovered disease causing mutation (Botstein & Risch, 2003; Rabbani, Tekin, & Mahdieh,
2013; Bao et al., 2014).
ANNOVAR is one of the annotation tools that prioritise candidate genes. It is a fast and
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efficient tool that can perform gene-based, region-based and filter-based annotation of the
functional consequences of genetic variant (K. Wang, Li, & Hakonarson, 2010). ANNOVAR
has the ability to calculate the score for all popular annotation software such as SIFT (Ng &
Henikoff, 2003), Polyohen2 (Adzhubei et al., 2010), MutationTaster (Schwarz, Rödelsperger,
Schuelke, & Seelow, 2010), MutationAssessor (Reva, Antipin, & Sander, 2011), FATHMM
(Shihab, Gough, Cooper, Day, & Gaunt, 2013), VEST (Carter, Douville, Stenson, Cooper, &
Karchin, 2013), CADD (Rentzsch, Witten, Cooper, Shendure, & Kircher, 2018), and GERP++
(Davydov et al., 2010). Each step of the downstream analysis are essential to ensure getting
the true and accurate result to detect mutations. However, it relies mainly on the sensi-
tivity and the accuracy of discovering the variant from VC tools. However, in our project,
we aim to assess and focus on variant identifications on the African versus European populations.
Figure 1.1: An overview on the WGS Data Analysis Pipeline.
Figure 1.1 presents a simple and general overview on the process of analysing the generated raw
data, it may differ with some researchers whether to include more steps or less, first step is
pre-alignment which include quality control and reads trimming, the second is alignment to a
reference genome, third is after-alignment which include: sorting the reads, marking duplicate,
and recalibration, after this reads are ready for variant calling, last but not least comes the
annotation and finally the diagnosis and result.
Despite the major genetics differences and variations between various populations, the
African populations yield the highest level of genetics variations among them, yet, it is still
under-represented. While most of the next-generation sequencing and downstream data analysis
tools are using European genetics data, this may affect the identification of population-specific
variants associated with diseases or variable traits (Campbell & Tishkoff, 2008). Additionally,
there are many variant calling tools and considering that majority of NGS downstream analysis
tools has been performed and tested in European sequence data (Campbell & Tishkoff, 2008),
one can be confused to which one of these current tools can have the highest accuracy with
low false positive and false negative rate, especially when dealing with African sequence data
sets. However, it is critical to note that discovering population-specific variants associated with
diseases in the African populations would enable a range of applications from medical population
genetics to precision medicine.
A number of previous studies has evaluated variant calling tools on specific populations,
yet rare or little evaluated them on African populations. Here in this project, we will evaluate
and assess nine different variant calling tools on both African and European populations at
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different coverage depth. According to the review done by (Mielczarek & Szyda, 2016), that an
accurate variant calling requires high sequencing depth. In addition to this, it enables to utilise
the information on the quality of individual reads, therefore providing measures of uncertainty
on every predicted variant.
In this project we have chosen the most known and open-source variant calling tools, which
are VarScan2 (Koboldt et al., 2012), SAMtools (H. Li et al., 2009), GATK-HaplotypeCaller
(McKenna et al., 2010), SNVer (Wei, Wang, Hu, Lyon, & Hakonarson, 2011), BCFtools (H. Li,
2011), FreeBayers (Garrison & Marth, 2012), Lofreq (Wilm et al., 2012), PlatyPus (Rimmer,
Phan, Mathieson, Iqbal, & Twigg, 2016) and VarDict (Lai et al., 2016), see (Table 3.1), we
excluded other variant calling tools as we follow (Sandmann, De Graaf, et al., 2017) exclusion
criteria which is either they are using same tool or they required matched sample or calling
Indels. we also excluded somatic variant calling tools.
1.7 Variant Calling
After finishing with Next Generation Sequencing, researchers and bioinformaticians have faced
challenges with enormous amount of raw data (FASTQ file), which contain the DNA sequence
of individuals. The FASTQ file needs to be aligned to a reference genome file which will produce
SAM/BAM file. After Alignment, the SAM/BAM file will contain genetic differences that need
to be identified; this step is called variant calling (VC), which is represented in the Variant Call
Format (VCF) file.
The genetic variations and polymorphisms are identified by variant calling tools, and these
variations are classified into different categories, such as somatic variants, germline (inherited)
variants, structure variants (SVs) and copy number variants (CNVs). Moreover, these variations
differ and rapidly evolve beyond single nucleotide polymorphisms (SNPs), to another different
kind of complexity such as short insertions and deletions (Indels), short tandem repeats (STRs)
and multi-nucleotide polymorphisms (MNPs) (Tan, Abecasis, & Kang, 2015). If these genetics
variations are well defined and accurately annotated, they can help identifying mutations of
which information can improve clinical diagnosis. of course, not all genetics variations are
diseased or fatal; some of these variations make individuals unique and different from one to
another.
1.7.1 Algorithms used to call the variant
Numerous Algorithms have been designed to detect and discover variants. There are two
main approaches applied by current tools to discover variants, the heuristic approach and the
statistical approach.
1.7.1.1 Heuristic approach
The heuristic algorithm can resolve the genotypes of the normal and tumor samples depending
on reads quality, coverage depth and allele frequency, all along with the statistical significance to
detect variants (Koboldt et al., 2012). One of the variant calling tools applying heuristic methods
is VarScan2, along with Fisher’s exact test can call somatic variants and germline variants
(Koboldt et al., 2012). Varscan2 can differentiate between somatic variants and germline variants
by comparing between normal and tumor genotypes. if the variants are in both genotypes are
called somatic, while if it heterozygous in normal and homozygous in tumor are called as Loss
of heterozygosity (LOH), and if the variants are shared among samples are called as germline
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variants (Koboldt et al., 2012). The heuristic method requires high computational demands, in
effect, it not usually applied by other variant calling tools (Mielczarek & Szyda, 2016).
1.7.1.2 Statistical approach
Genotypes calling by the probabilistic method is the calculation of the statistical uncertainty for
the called genotype, and it adopts Bayes’ theorem (Mielczarek & Szyda, 2016). This algorithm
is implemented by GATK variant caller (McKenna et al., 2010). It calculates raw genotypes
likelihoods using a Bayesian model ( Equation 1.1) used in GATK tool, showing the probability
of a candidate genotype P (Ri|Gl), for a diploid genotype Gi, consist of one copy of allele A1,
and one copy of allele A2, it indicates the mean read likelihoods for alleles in specified genotype











Furthermore, to calculate the posterior probability of each candidate genotype P (Gl|Ri) is





The numerator consists of the product of the prior probability of a genotype P (G) and a
raw genotype likelihood divided by the sum of the likelihoods of all the possible genotypes for
the set of alleles called in the variant (McKenna et al., 2010).
1.8 Previous Studies Comparing Variant Calling Tools
There have been several studies that investigated and compared different variant calling tools on
their own parameters and population, but, none of them has used African sequence data set or
related simulation data set in doing so. Some of these benchmark studies differ in characteristics
(whole genome, whole exome), (somatic variant or germline variants) and evaluation parameter
but, most of these studies agreed on detecting true variants with high accuracy and specificity.
Furthermore, many authors compared their tools on different depth of coverage reads, as
these are important parameters to detect variant from NGS reads. The higher the read depth
coverage, the more confident base calls, and more distinguishable from the sequencing error
(Cheng, Teo, & Ong, 2014), accordingly, many studies used high coverage read sequence depth
as it improves the accuracy of variants calling. Other studies consider variant filtering to be a
suggested step as it could improve the specificity and sensitivity, and reduce false-positive rate
(Spencer et al., 2014).
Numerous studies such as (Zook et al., 2014; Laurie et al., 2016; Kumaran, Subramanian, &
Devarajan, 2019) and others have bench-marked variant calling tools using the set of NA12878
Genome in a Bottle (GiaB) high confidence GRCh37 variants as a gold standard reference set,
whereas other previous studies include (Liu, Han, Wang, Gelernter, & Yang, 2013), has used
WES data to benchmark VC tools, while other studies used simulated data as a gold stander.
While some authors evaluated VC tools with different coverage to see which tool performs best,
(Stead, Sutton, Taylor, Quirke, & Rabbitts, 2013) suggested that VaraScan2 perform very well
with different sequence depths, as they were assessing sequence depth that is required to detect
low-allelic variants.
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(Pabinger et al., 2014) have surveyed more than 60 variant calling tools and compared 9 VC
tools, somatic and germline callers respectively, they suggest to use several variants calling tools
for a better resul. (Bao et al., 2014) recommended to apply multiple tools to call the variant
in order to reduce false-positive and increase sensitivity. Additionally, (O’Rawe et al., 2013)
have evaluated VC tools on both whole exome and wholes genome sequence data, suggesting to
study larger multi-generational families in order to increase the accuracy of detecting de-novo
variants.
Several studies have focused on detecting the somatic variants (known as low-frequency
variants) to discover cancer mutations, they have compared different somatic variant calling
tools such as VarScan2 (Koboldt et al., 2012), GATK haplotype caller(McKenna et al., 2010)
(Q. Wang et al., 2013; Roberts et al., 2013; Spencer et al., 2014; H. Xu, DiCarlo, Satya, Peng,
& Wang, 2014; Alioto et al., 2015; C. Xu, 2018) (they increase sequence depth up to 100 and
apply PCR free methods which show significant benefits).
Apart from this, (Pirooznia et al., 2014) have compared two variant tools with realignment and
recalibration steps, they suggested realignment/recalibration increase further the accuracy of
the call.
Similar to other studies such as (Yu & Sun, 2013; Liu et al., 2013; Cornish & Guda, 2015; Laurie
et al., 2016) founding that GATK UG has yielded high-quality variant calls outperforming others.
In contrast, studies in (Yi et al., 2014; Pirooznia et al., 2014; Warden, Adamson, Neuhausen,
& Wu, 2014) suggested that GATK HC was the best. Despite several studies suggested to
use GATK; however, the unfavorable thing with GATK is the long runtime (Warden et al.,
2014; Talwalkar et al., 2014; Huang et al., 2015; Laurie et al., 2016; Sandmann, De Graaf, et
al., 2017; Z. Li, Wang, & Wang, 2018). Also, another downside with GATK is the inability to
detect low-frequency variants (Cheng et al., 2014) of which might characterised populations
with high diversity and with low level of linkage disequilibrium. In contrast, (Hwang, Kim, Lee,
& Marcotte, 2015) suggested to use Samtools when dealing with SNP and GATK HC when
calling Indels. Among all these studies, (Huang et al., 2015) have evaluated different tools by
using pooled samples and they conclude that LoFreq(Wei et al., 2011) had high sensitivity and
low false-positive variants.
Alternatively, other studies such as (Bao et al., 2014; Pantano, 2016; Laurie et al., 2016; Said
Mohammed et al., 2018) recommended to use FreeBayers. Whilst, others recommend Vardict
such as (Sandmann, De Graaf, et al., 2017). The same study (Sandmann, De Graaf, et al., 2017)
concluded that LoFreq, VarDict, FreeBayers (Garrison & Marth, 2012) and SNVer have had
detected variants with low allele frequency.
Overall, large data such as Whole-genome sequencing may be a challenge to filter out
false positive, one of the new emerging trend to handle such a huge size is applying machine
learning algorithms (Zook et al., 2014), several recent new tools used this algorithm such as
decision-tree-based methods such as FUWA (Z. Li et al., 2018), random forests such as SNooPer
(Spinella et al., 2016) and many others, which can learn the excellent way to filter out genotypes
error. Finally, among all these previous studies, and to our best of knowledge, there is limited
or no studies have compared different variant calling tools on the African populations. Study
as (Cheng et al., 2014) who did Southeast Asian Malays population-based sample to analyse
and assess VC tools, are a good example to follow and apply on the African populations. Since
there no agreement on which tool to use, and with so many recommendations, one has confused.
In this study, we will illustrate and evaluate nine different variant calling tools on African
population whole-genome data. In our project, we excluded indels, somatic and structural
variants since it required a different set of algorithms.
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1.9 Evaluation Metric of Variant Calling
As suggested and agreed by many studies that sensitivity and specificity are one of the key metrics
of evaluating variant calling tools. There are different evaluating metrics such as sensitivity, pos-
itive predictive value (PPV), false-positive rate (FPR), F-score, and the Transition/transversion
(Ti/Tv) ratio.
False Negative and False Positive
A variant calling tool can classify variants whether it is positive or negative depending on
the caller, and depending on the benchmark validation dataset can confirm if it is true-
positive/negative or false-positive/negative variants (Talwalkar et al., 2014).
The sensitivity (also known as recall) of the variant calling tool, is the measurement of the
actual true positive in the total called variants, and as shown in Equation 1.3 sensitively is





Many techniques and steps are important to increase the sensitivity from pre-data processing
such as increasing sequence depth, till post- variant calling step as filtering variants. Further-
more, as suggested by (Depristo et al., 2011) who proposed GATK-Best Practices Workflows,
recalibration, local realignment and marking reduplicate are equally essential. Whereas Positive
Predictive Value (known as precision), as shown in Equation 1.4, is calculated by dividing TP
by the total of TP and FP. Moreover, a higher rate of false-positive and false-negative may be
caused by Short Reads sequencing (SRS)(Caspar et al., 2018).




Other metrics are as equally important and can be calculated as fellow:
False Positive Rate (FDR), is the ratio of false-positives to all total variant call as shown
in Equation 1.5, researchers as (Farrer, Henk, MacLean, Studholme, & Fisher, 2013) have





F-score is known as the harmonic mean of sensitivity and the positive predictive value, the
higher the F-score, the higher the accuracy. It can be calculated as shown in Equation 1.6.
F − score = 2TP
(2TP + FP + FN)
(1.6)
One of the Post-Alignment steps is to remove duplicate reads, by filtering alignment from
PCR amplifications that introduce duplicate reads which may lead to call false positive variants
(Hintzsche, Robinson, & Tan, 2016). Furthermore, (Farrer et al., 2013) concluded that read-
trimming has decreased the per cent of false-positive SNPs (Durtschi et al., 2013).
Transition/transversion ratio
Almost all of these studies have compared the tools by evaluating their sensitivity, specificity
and Ti/Tv ratio. The higher the ratio of Ti/Tv, the higher the accuracy of variant call tool,

















































Table 1.1: Comparisons of previous studies for different variant calling tools.
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1.10 Overview of Mutations in The African Populations
Africa considered the utmost sources of modern humans, and have the greatest genetics variation
in the world. For this reason, it is crucial to study and investigate the admixture event and the
pattern of ancestral migrations that led to genetic variations, by characterising these genetic
variations in the African populations (Choudhury, Aron, Sengupta, & Hazelhurst, 2018). This
will provide a fundamental understanding of how genes contribute to phenotypic variations,
response to the pharmaceutical drugs, susceptibility of infectious diseases such as Tuberculosis
(TB), malaria, HIV/AIDS that are considered as a major burden in Africa.
Likewise, the importance of understanding human historical background, biology and the
differing distribution of diseases frequency by ancestry and geography (C. N. Rotimi et al.,
2017), since the human demographical history, migrations, adaptation, population admixture
and expansion, shape the genetic variation and disease susceptibility in Africa .
Furthermore, the urbanisation expansion in Africa has increased the prevalence of infectious
diseases alongside with non-communicable disease in low- and middle-income African countries
(Oni et al., 2015).
Moreover, the achievement of linkage studies and genetic association studies such as genome-
wide association studies (GWAS) have shed light on the diversity of human genome. While, in
Africa, research projects such as the Human Hereditary and Health in Africa (H3Africa) has
prompted the studies of genetics and genomics, yet, current knowledge on African genetics and
genomics is still at infant level. Because not only the discovery of the structural complexity of
the genetic mutations in the African populations is critical, but also, it is important to return
the secondary findings that are known as actionable genes as recommended by the American
College of Medical Genetics and Genomics (ACMG). Therefore, it requires more investigations
and studies to improve public health and diminish the heavy burden of genetic diseases in the
African continent (Choudhury et al., 2018; Mboowa, 2019).
Here we will illustrate genes that are associated with each different diseases. In this section,
we will give a brief background on each disease such as infectious diseases (ID): HIV/AIDS,
Malaria, Tuberculosis, and non-infectious diseases: sickle cell disease and its related genes
reported by previous researched studies, and we will also investigate previous studies on the
secondary (incidental) finding (actionable genes) specifically for African population.
1.10.1 Communicable Diseases: Susceptibility of Infectious Diseases
in Africa
Understanding the genetics of diseases susceptibility and diseases resistant is important in order
to improve diagnosis, treatment, disease prevention, and health in general. As such an example,
(Sirugo et al., 2008) is one of the previous genetic studies of Africa that reviewed most of diseases
susceptibility and response to the vaccine and therapeutic, the authors have illustrated the
genetic association and the genetic background of the most common infectious diseases in Africa.
1.10.1.1 Tuberculosis
Tuberculosis(TB) is an infectious disease caused by the bacteria called Mycobacterium tubercu-
losis, and it mainly affects the lung. TB is considered as one of the devastating diseases in the
world, and according to the World Health Organisation (WHO) 10.0 million individuals are
affected with TB worldwide, and the majority of them are African https://www.afro.who.int/
health-topics/tuberculosis-tb. Consequently, Africa has the highest TB incident per capita,
with high rate of HIV/TB co-infection (Dye et al., 1999; Wood et al., 2010). The co-morbidity
of HIV and TB in Africa is common, which make it difficult to analyse TB in Africa, according
to this it is important to investigate the genetics susceptibility of TB considering co-infection
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with HIV. From many genes known to be associated with TB, we have collected 136 genes
(supplementary information in the Appendix) from different literature mostly from (Sirugo et
al., 2008) and from other gene-diseases databases as will be described in next method section.
Genes like SLC11A1 (Søborg et al., 2007), vitamin D receptor gene are associated with TB
susceptibility, while other genetic association such as a novel in chromosome 11p13 causes
resistance to TB (Thye et al., 2012), this was confirmed by GWAS study done by (Chimusa
et al., 2014) on South African Colored (SAC) population. Furthermore, previous studies such
as (Davila et al., 2008; Salie et al., 2015; Schurz, Daya, Möller, Hoal, & Salie, 2015; Schurz
et al., 2018) have investigated the influence and association of toll-like receptor (TLR) family,
which has an immune response against invading pathogens. Further, according to (Möller &
Hoal, 2010), African were twice as likely to be infected with M. tuberculosis than individuals
with European ancestry, which demonstrates the necessity for well-integrated investigations of
African genomics information and variations.
1.10.1.2 Malaria
Malaria is caused by Plasmodium species parasite, and four species of Plasmodium infect
humans P. falciparum, P. malariae, P. ovale, P. vivax and more recently P. knowlesi. In
2018, 93% of malaria cases occurred in Africa, sub-Saharan mostlyhttps://www.afro.who.int/
health-topics/malaria. Most of malaria mortalities are children(Kwiatkowski, 2005). Several
genetic variations causes malaria resistance in Africa, such an example, the mutation in Hbs of
the β globin gene, which leads to sickle cell disease, another is Duffy gene (Campbell & Tishkoff,
2008). Studies by (Sirugo et al., 2008; Jallow et al., 2009) have reviewed the genetic of malaria
susceptibility genes association. For example, CD40 ligand, CD36, Haptoglobin genes cause
severe malaria in the African populations (Sirugo et al., 2008). Thus, it is crucial to investigate
malaria infection susceptibility and resistance from an inter-ethnic African population groups.
We have collected a list of genes associated with susceptibility and resistance of malaria disease
and they are presented in (Table A.1) in the supplementary information in the Appendix.
1.10.1.3 HIV/AIDS in Africa
Acquired immunodeficiency syndrome (AIDS) is a lethal life-threatening disease caused by the
human immunodeficiency virus (HIV). AIDS affected more than 35 million individuals worldwide,
majority of infected region are in Africa https://www.afro.who.int/health-topics/hivaids.
Many studies have investigated the genetic association of the susceptibility and resistance of
HIV/AIDS (Sirugo et al., 2008; Joubert et al., 2010; Vannberg, Chapman, & Hill, 2011; Peer,
2015). Further (Picton, Paximadis, & Tiemessen, 2010) studied the association of polymorphic
variation of Chemokine (CC motif) receptor 5 (CCR5) gene in HIV-1 infected/uninfected South
African population. We have collected a list of genes associated with susceptibility and resistance
of HIV/AIDS shown in (Table A.1) in the Appendix.
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1.10.2 Non-communicable Diseases in Africa
1.10.2.1 Sickle Cell Disease
According to WHO https://www.afro.who.int/health-topics/sickle-cell-disease, Sickle
Cell Disease (SCD) is considered as a major and common cause of illness and mortality in the
world (Makani, Williams, & Marsh, 2007). Furthermore, the majority of newborns affected with
SCD in the world are in Africa; as a result, it is considered as the main birthplace of sickle
mutations (Diallo & Tchernia, 2002; Mboowa, 2019), as illustrated in Figure 1.2 obtained from
(Piel et al., 2017).
Figure 1.2: Worldwide Number of Newborns with Sickle Cell Anemia from (Piel
et al., 2017).
SCD is a single gene disorder caused by a single nucleotide mutation (HBB : c.20A > T )
in the human β globin gene (HBB) (located on chromosome 11p15.5), which gives rise to a
hemoglobin structural variant (HbS) (David et al., 2018). The mutation in HbC and HbS,
cause a substitution of glutamic by lysine or valine, respectively (Agarwal et al., 2000). The
homozygosity for the globin S gene mutation (HbSS ), is the most common genotype leading
to SCD in Africa (Makani et al., 2007), occurs on five ”classical” β haplotype backgrounds in
ethnic groups of African ancestry. A number of previous studies observed the association of HbF
with the BCL11A locus on chromosome 2p, and with a broad region around the c-Myb locus
(called HBS1L-MYB) and within the β globin (Orkin & Bauer, 2019; Wonkam et al., 2019).
Furthermore, the human leukocyte antigens HLA DRB1*1302 haplotype and HLA-B53 are
associated with protection from both forms of the severe disease (Agarwal et al., 2000). Fetal
haemoglobin (HbF) is an heritable trait that influences the clinical course of sickle cell disease.
Study by (Wonkam et al., 2014) had investigated the relationship between HbF levels and the
relevant genetic loci in 610 African patients with SCD. Furthermore, the causes of death in
affected children are poorly documented, despite the high mortality associated with SCD in
Africa, (Rees, Williams, & Gladwin, 2010). Retrospective design done by (Macharia et al., 2018),
described the clinical epidemiology of SCA within a malaria-exposed among African populations,
suggesting attention to be payed on SCD care and treatment to reduce high child-mortality.
We have collected a list of genes associated with SCD and are displayed in the supplementary
information in the Appendix section (Table A.1).
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1.11 Secondary Finding (Actionable Genes)
In 2013, The American College of Medical Genetics and Genomics (ACMG) provided a rec-
ommendation and policy to return secondary finding in 56 genes associated with medically
actionable conditions (Green et al., 2013; ACMG, 2015). Secondary finding (also known as
accidental finding) provides information about genes unrelated to the primary cause of testing.
Several studies such as (Berg et al., 2013) investigated actionable secondary findings following
ACMG policy, and have been carried out on different populations. A study by (Dorschner et
al., 2013) have identified actionable finding in 1,000 individuals (500 African and European,
respectively), they return a result of 114 genes reported as actionable genes. They have classified
the variants into four criteria, (1) pathogenic, (2) likely pathogenic, (3) variant of uncertain
significance (VUS), (4) likely benign VUS. Furthermore, the variants that classified as pathogenic
in the European population are expected to be pathogenic in other populations as the African;
however, variants that do not occur in the European population are understudied (Dorschner et
al., 2013). This may lead to miss some pathogenic variants in the African population; therefore,
it is important to update additional African-specific actionable genes.
With the same objective, (Amendola et al., 2015) and (Olfson et al., 2015) both conducted
secondary findings with the majority of the identified medically actionable genes found in the
European populations, while the lowest found in the African populations. Some studies return
secondary findings regarding specific populations, as the study by (Ploug & Holm, 2017), was
on the Danish population, they suggested a new policy for reporting incidental findings (IFs) by
performing a choice-based conjoint survey. Moreover, (Tang et al., 2017) have done the same
project in the east Asian populations among 954 individuals.
Meanwhile, other studies have focused on disease-specific secondary findings, for example,
(Tetzlaff et al., 2016) have returned secondary findings in sebaceous carcinoma, other like
(Thompson et al., 2018) investigated on secondary findings of developmental delay and intellectual
disability in children. There are many research initiatives that have recommended guideline and
policies in returning IFs, such as, ACMG (ACMG, 2015) in the United States, EuroGenTest and
the European Society of Human Genetics (Matthijs et al., 2016) in Europe, and the Association
for Clinical Genetic Science (ACGS) in the United Kingdom (Wallis et al., 2013), yet there are
no polices on reporting IFs (Bope et al., 2019) in Africa.
Unfortunately, the absence of major representation of genetic studies on African populations
could lead to rule out some novel variants that may consider as a pathogenic actionable genes
— taking into consideration that African descent populations have high diversity and genetic
variations. Regarding this matter, many researches and enterprises in Africa have increased,
such as the resent policy guideline on feeding back findings by the Human Heredity and Health
(H3Africa). Moreover, the study report done by (Bope et al., 2019), provided list of available
WGS/WES of the African genome data, reviewed in-silico prediction mutation tool, further, they
have recommended several points, to benchmark variant calling tools using African populations,
develop a reference panel specific to the African genome, in order to improve the clinical outcomes
and overall health in the African continent. Regarding previous literature, in this project, we
will investigate secondary findings of disease-specific (HIV/AIDS, Malaria, Tuberculosis (TB),
and Non-communicable diseases such as Sickle cell disease) in 20 worldwide ethnic groups with
focus on the African ethnic groups. We have collected specific gene lists from literature (Sirugo
et al., 2008; Dorschner et al., 2013), GWAS Catalog, Actionable Genome Consortium (ACG),
and gene-diseases database such DisGeNET as will be discussed in Chapter 4. The full lists of





The development of computational algorithms and bioinformatics tools are well-demanded needs,
to handle, interpret and to perform analyses on enormous amount of large-scale raw DNA
sequence data that yield from Next-Generation sequencing NGS platforms. This with hope to
be able to provide answers to current diagnosis and precise treatment and prevention challenges.
DNA sequence synthetic data works as a robust appliance to benchmark and to allow new
development of bioinformatics algorithms and tools, as they can imitate sequencing error and
mutations error, and working as a gold standard.
The benefits of using simulated data is to be able to develop, validate, and pinpoints weakness
of bioinformatics tools and assess results (Myers, 1999). In addition, Since, simulated DNA
sequence known as synthetic reads; thus, there is no ethical approval or security requirement
and the simulation data are produced at a low cost. Moreover, simulation tools allow users
to hold control on inserted parameters and expected variants (Holtgrewe, 2010). Furthermore,
users can generate as much reads as desired, with predefined parameters of choice for which true
values are known to allow validating result agaisnt true/golden values or data. consequently, the
genetic and genomics simulated data have become increasingly popular to assess and validate
the biological model in order to test a new hypothesis, help to design and extrapolate specific
data set (Escalona et al., 2017).
2.1.1 Overview on Different NGS Simulation Tools
Many NGS simulation tools have been developed in the past few years. These tools vary in
their features, functionalities and input requirement and their output. Furthermore, a given
simulations tool differs to other on sequence parameter features or error profile and rate or it
was designed for a sequencing platform, either it represents Illumina, Roche’s 454 (454), Thermo
Fisher’s(SOLiD), Thermo Fisher’s IonTorrent, pacific Bioscience (PacBio), Oxford Nanopore
sequencing, Sanger sequencing, or either it was a platform-independent such as NEAT-genReads
(Stephens et al., 2016). Table 2.1 demonstrates different NGS platforms and their features
and their error profile and rate, which may be used as an input model for the simulation tools.
Moreover, they also differ in several aspects, such as the type of reads, whither it single-end,
paired-end or mate-pair, furthermore, the error model, coverage and the presence of genomics
variants.
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Table 2.1: Main characteristics of NGS technologies and examples of simulation
tools representing these platforms (Escalona et al., 2017).
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2.1.2 General process of DNA read simulation
Despite the different features of reads simulation tools, they all have numerous features in common
with some exceptions. For example, the reference sequence, error profile indicate predefined parameters
such as type of variations and error distribution, and last the output is either aligned or unaligned
reads in different standard file format, such as FASTA, FASTQ, BAM, VCF and SFF (Escalona et al.,
2017). Figure 2.1 illustrates the general processes of DNA read simulation.
These error models may differ in their biological features such as GC content, Indels, and substitutions,
moreover differ in technological features representing various NGS platforms errors as indicating in
(Table 2.6). They may differ also in controlling the inserted parameters such as read length, quality
score and modelling PCR amplification and artefacts. Additionally, they also differ in using statistical
algorithms such as using empirical error probabilities as in Mason (Holtgrewe, 2010), probabilistic
model of biased sampling distribution as in FASIM (Hur et al., 2006), using configurable statistical
models such as 454sim (Lysholm et al., 2011), or stochastic grammar to model tandem repetitive arrays,
large scale duplication as in Celsim (Myers, 1999), and finally, as in Metasim using Yule-Harding model
to generate phylogeny tree and Jukes-Cantor formula to estimate probabilities of the change in each
base pair (Richter, Ott, Auch, Schmid, & Huson, 2011).
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Figure 2.1: Overview of the general Simulation process.
As shown in Table 2.1, BEAR (Johnson et al., 2014) can simulate Ion torrent platform even it is
a platform-independent, it also used to simulate metagenomic data. Another example of simulation
tools that can simulate DNA sequence reads without a reference sequence is XS developed by (Pratas,
Pinho, & Rodrigues, 2014). With such many simulations tools and features, one can ask which tools
to use when simulating NGS reads. Well, there are two reviews one by (Escalona et al., 2017) and
(Alosaimi et al., 2019), these reviews illustrate and define different DNA sequence simulation tools
with a decision tree to allow users to make their choices.
In this research project, NEAT-GenRead (Stephens et al., 2016) was chosen; it is a WGS simulation
tool. The software allows user to control the mutation model, sequencing error model, and adjusting
parameters. It is platform-independent, can simulate SNPs, Indels and any ploidy. Also, it can accept
variants as an input, it output Golden VCF and Golden BAM to benchmark other tools. Since, our
study aims to choose best variant calling tools that have low FP, FN rate and works best with African
populations, NEAT-genReads is the choice as we can mimic the African variation by using real African
data as an input in the mutation model, as well as for the European populations.
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2.2 Materials and Methods
To simulate DNA sequence samples, we have used NEAT-GenRead (Stephens et al., 2016). Figure
2.2 shows NEAT simulation pipeline, NEAT-GenRead is one of the NGS simulating tool written in
python and it outputs in three different files: The forward and reverse Fastq and golden Bam and
Golden VCF. It can mimic real data by using models learned from specific data sets. We have used
two models from NEAT-GenRead which are mutation models (genMutModel.py) and sequence error
model (genSeqErrorModel.py), (https://github.com/zstephens/neat-genreads.
Figure 2.2: Sketch of the method used in NEAT-GenReads.
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2.2.1 Data Description
2.2.1.1 Mutation Model
The data we have used is from the 1000 Genome Human Project (Consortium et al., 2012), which is
publicly available, and no ethics approval was needed. To generate mutation models, we have used
only one random sample (as suggested in NEAT manual) to mimic each population, for the African
population we used one random sample (sample ID NA18881) from Yoruba in Ibadan, Nigeria (YRI),
and for the European populations, we used a sample ID NA11930 from Utah Residents (CEU) with
Northern and Western European Ancestry. Using a population-specific mutation model, we were able
to make the result more accurate and confidently representing the population. We have chosen YRI
and CEU as they are commonly been used a proxy for African and European populations, respectively.
2.2.1.2 Sequencing Error Model
The forward and reverse Fastq files are the raw files produced from the DNA sequencing platforms.
As the same for the mutation model, we used Fastq file specific for each population. Since NEAT is
platform-independent, we have chosen to mimic Illumina sequencing Single-pass error rate, and final
error rate 0.1, which are mostly from SNPs substitution (Pfeiffer et al., 2018), basically using the
same targeted sample, NA1888 for YRI and NA11930 for CEU.
2.2.2 NEAT-GenReads
We performed simulation by using NEAT-GenReads, we used hg38/GRCh38 the latest human reference
genome as an input to be used for generating simulated reads. NEAT-GenReads needs target variant.
As a result, we have used 50 African samples and 50 European samples as listed in Table 2.2. We
extracted common variants from each individual by using a custom python script. The mutation rate
was set at 0.1, to resemble Illumina sequencing platforms.
Table 2.2: Individuals from 1000 Genome Human Project, used for generating
target variants.
African Proxy Population
HG01879, HG01880, HG01882, HG01883, HG01885, HG01886, HG01889, HG02461, HG02462,
HG02464, HG02465, HG02561, HG02562, HG02567, HG02922, HG02923, HG02938, HG02941,
HG02943, HG02944, HG02946, HG03052, HG03054, HG03055, HG03057, HG03058, HG03060,
HG03061, NA18486, NA18487, NA18488, NA18489, NA18498, NA18499, NA18501, NA19023,
NA19024, NA19025, NA19026, NA19027, NA19028, NA19030, NA19625, NA19700, NA19701,
NA19703, NA19704, NA19707, NA19711, NA19712
European Proxy Population
NA06984, NA06986, NA06989, NA07037, NA07048, NA07051, NA07347, NA11840, NA11843,
NA11893, NA11894, NA11918, NA11919, NA11920, NA11931, NA11932, NA11933, NA12045,
NA12058, NA12275, NA12282, NA12286, NA12340, NA12341, NA12342, NA12347, NA12348,
NA12399, NA12400, NA12413, NA12546, NA12716, NA12748, NA12749, NA12760, NA12775,
NA12776, NA12777, NA12778, NA12827, NA12828, NA12829, NA12830, NA12842, NA12843,
NA12878, NA12889, NA12890, NA12891, NA12892
Furthermore, we have generated two data-set (African and European) with two different depth
coverage. Each population has 50 samples, of which 25 are high coverage, and 25 low coverage.
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2.3 Results
One hundred samples successfully simulated, of which 50 representing the African population (25/25
samples with high/low coverage sequence ) and 50 representing the European population (25/25
samples with high/low coverage sequence ). NEAT-GenReads output forward and reverse FastQ file,
golden BAM and golden VCF. We divided it into 4 data sets (AFR high, AFR low, EUR high and
EUR low).
The NEAT-GenReads scripts were submitted by using the vertical cloud of the Centre for High-
Performance Computing (CHPC) in the Republic of South Africa https://www.chpc.ac.za. The
Resulted files are stored at CHPC for further manipulation and analysis. The simulations processes
take up around 400 CPUh, almost over two weeks to be done.
As expected and known that African genomics data have more genetics variation than the European
population. Hence, the simulation results have met the expectations; the African simulated golden
VCF have more SNPs and variation than the European see (Table 2.2). Simulated data generated
represent whole-genome sequencing (WGS).
2.3.1 Assessing and Examining Simulation Outputs
2.3.1.1 Quality Control Check on the Simulated Forward and Reverse FastQ files
We have checked the quality of the generated FastQ files by using FastQC (Andrews et al., 2012)
https://www.bioinformatics.babraham.ac.uk/projects/fastqc/, to ensure that the reads of the
simulated raw data are in a good quality prior alignment to a reference genome and to be able to use
them for further processes as will be discussed in the next chapter.
We have run FastQC on all the resulted Forward and Reverse FastQ files, then we aggregate the
result from FastQC into a single report by using MultiQC (Ewels, Magnusson, Lundin, & Käller, 2016)
https://www.github.com/ewels/MultiQC. Figures 2.3-2.6 illustrates the report for reads quality
control. The summary evaluations of FastQC have resulted into six modules. The first is the sequence
counts for each sample (A) in Figures 2.3- 2.6. Second, comes the mean quality value across each
base position in the read, quality values across all bases at all position in the FastQ files which seem to
be very good quality calls (green), except for few samples in European High and low, has reasonable
score (orange) (B) in Figures 2.3- 2.6.
Third, per Sequence Quality Scores among all samples are good. C) in Figures 2.3- 2.6 show the number
of reads with average quality scores. These figures illustrates also if a subset of reads has universally poor
quality. Per Sequence GC Content (D) in Figures 2.3- 2.6 show the average GC content of reads, even
though, we did not use the GC-content model (was set as the default from the NEAT-GenReads). The
mean of CG-content was 40% which has a roughly normal distribution of GC content among all samples.
(E) and (F) in Figures 2.3- 2.6 show the percentage of the calls at each position for whichever an
N was called, (F) the relative level of duplication found for every sequence, respectively. The per base
N content, usually in the simulated samples, the value is always zero as well as our result.
Furthermore, the sequence duplication in the resulted report is good among all samples, the high
the level of duplication the more likely to indicate some kind of enrichment bias (e.g. PCR over-
amplification).
Accordingly, we have decided to use the Fastq files for further analysis to call the variants by nine
different variant calling tools and asses these tools by comparing the resulted VCF files with the Golden
VCFs.
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Figure 2.3: Aggregated Report from MultiQC of all the FastQC reports of the
simulated African- High coverage samples.
FastQC report shows (A)Sequence Counts. (B)Mean Sequence Quality score. (C)Per Sequence Quality
Scores. (D)Per Sequence GC Content. (E)Per Base N Content. (F)Sequence Duplication Levels.
Figure 2.4: Aggregated Report from MultiQC of all the FastQC reports of the
simulated European- High coverage samples.
FastQC report shows (A)Sequence Counts. (B)Mean Sequence Quality score. (C)Per Sequence Quality
Scores. (D)Per Sequence GC Content. (E)Per Base N Content. (F)Sequence Duplication Levels.
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Figure 2.5: Aggregated Report from MultiQC of all the FastQC reports of the
simulated African- Low coverage samples.
FastQC report shows (A)Sequence Counts. (B)Mean Sequence Quality score. (C)Per Sequence Quality
Scores. (D)Per Sequence GC Content. (E)Per Base N Content. (F)Sequence Duplication Levels.
Figure 2.6: Aggregated Report from MultiQC of all the FastQC reports of the
simulated European- Low coverage samples.
FastQC report shows (A)Sequence Counts. (B)Mean Sequence Quality score. (C)Per Sequence Quality
Scores. (D)Per Sequence GC Content. (E)Per Base N Content. (F)Sequence Duplication Levels.
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2.3.1.2 Golden BAM files
The total output was 100 Golden BAM files, 50 African(25 samples high coverage and 25 low coverage)
and 50 European (25 samples high coverage and 25 low coverage). The generated Golden BAM files
were good. Reads are sorted and coordinate; an example is shown in (Figure 2.7). We have examined
the Golden BAM files once manually with Samtools falgstat, quickcheck to check if their are qualities
are good, the result among all simulated golden BAM was good as indicated in (Figure 2.7b).
(a) Golden BAM header.
(b) Golden BAM flagstat result.
Figure 2.7: An example of Golden BAM header and flagstat.
However, we could not use BAM files generated fronm NEAT directly for variant calling as their
headers, particularly the group read (@RG) tag are the same among all files. @RG refers to a set of
reads that were generated from a single run of sequencing platform. Some variant calling tools such as
GATK requires unique @RG to be present in the VCF files, otherwise it will terminate with errors the
@RG is absent. We have tried to add a new @RG with Picard tool (AddOrReplaceReadGroups), and
Picard has failed to correctly replace group read. As a result, we have decided not to use golden BAM
as direct input for variant calling. Therefore, we chose to use Fastq files as shown in (Figure 1.1).
2.3.1.3 Golden VCF files
100 Golden VCF files were generated, 50 African (25 samples with high coverage and 25 low coverage)
and 50 European (25 samples with high coverage and 25 low coverage). Generated Golden VCF will
be used to compare and assess the VCFs generated from 9 different state-of-the-art variant calling
tools. Table 2.3 presents a summary of the variants in the generated VCF files.
Table 2.3: Total variants number present in the golden VCF files gnerated by
NEAT-GenReads for African and European Populations.
Variants numbers present in golden VCF
Population African Populations European Populations
Coverage High Low High Low
Number of
samples
25 25 25 25
Variant
number
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2.4 Brief Discussion and Chapter Summary
The DNA sequence simulation was done using NEAT-GenReads. NEAT-GenReads is an excellent
DNA sequence simulation tool, user-friendly and easy to use as suggested in (Alosaimi et al., 2019).
NEAT-GenReads allows users to adjust the input parameters, setting desired DNA sequence coverage
and generating specific mutation model. It implements three models including the mutation, GC-
content and sequencing models of which we used two mutation and sequencing models. However, we
used default setting for the GC-content model (Stephens et al., 2016).
We generated two simulations data sets each representing a specific population, African and European
populations. NEAT-GenReads output three different files, Forward and reverse Fastq, Golden BAM and
Golden VCF, thus, the total outputs are 100 sample, 50 samples representing the African population
with two different coverage (high and low) to check the effect of sequence coverage on variant calling,
as well as for European population ( Figure 2.2 and Table 2.2).
As expected, the variations in the African samples was higher than the European ones. NEAT-
GenReads was able to mimic both populations as we allowed NEAT to learn from population-specific
data and the generated population specific models. The resulted Fastq files, as stated in the result
section, was in good quality for both populations, and we used as for our further analysis. On the other
hand, Golden BAM was not used as the group read (@RG tag) was missing, this is one limitation of
NEAT. Consequently, we decided to use Fastq files for our further analysis in the next chapter.
Additionally, the generated Golden VCF was good; as a result, it will be used as a baseline to benchmark
and evaluate nine different variant calling tools (see Chapter 3).
In summary, in this chapter, we have described the process of DNA sequence simulation tools, and
we have illustrated some example for each tool representing different NGS platforms. However, our
aim in this chapter was to simulate DNA sequence reads. We choose NEAT-genReads as a simulator,
it outcomes three different files format, FASTQ, Golden BAM, and Golden VCF. We have generated
two simulated data set each representing the African and European populations, respectively.
We have evaluated the simulation outcome to ensure our result is not truncated or damaged. We have
checked the quality of FastQ files by using FastQC tool, checking golden BAM, VCF by using samtools
features.
In the next chapter, we will use the simulated data (generated Fastq files) for further investigation
and evaluation following the NGS downstream analysis pipeline toward variant discovery from nine
different variant calling tools. We will evaluate the obtained resulted variations (VCF file) from each
tool against simulated Golden VCF.
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Chapter 3
Assessment of Nine Different Variant
Calling Tools on African Versus
Non-African Populations
3.1 Introduction
Whole-Genome Sequencing (WGS) data have revealed an insight into genome biology and genomics
filed. WGS have increased the understanding of diseases and even human history and have enlightened
the path toward personalised medicine. Furthermore, using whole-genome sequencing of multiple
samples will help improving performance measurements (Highnam et al., 2015). Also, analysing
WGS can allow detecting variants that are in a difficult region such as deep introns, which is hard
to explicate at DNA level (Caspar et al., 2018). However, WGS may cause uncertain mappability
due to the read length, dependency on the sequence coverage and model implement in variant calling tool.
Alongside with the tremendous advancement of Next-Generation Sequencing (NGS) technologies,
accompanying with cost reduction in genomics research have yield an enormous amount of DNA
sequence raw data, which have challenged the bioinformaticians to develop tools to analyses and
process such large-scale data. Furthermore, recent developments in the field of Next-Generation
Sequencing (NGS) technologies have led to insight toward disease etiology, diagnosis, and therapy for
the world’s utmost intractable destructive diseases such as HIV/AIDS, Malaria, Tuberculosis (TB), and
Non-communicable diseases such as Sickle cell disease and others (C. Rotimi et al., 2014), these diseases
are known to have the highest prevalence rate in Africa. However, despite the development in NSG and
the tremendous amount of knowledge in the genetics field, yet studying the genetic background of the
African populations still under-represented and have low participation in the genomics and genetics
studies (Retshabile et al., 2018). African populations harbour the greatest genetic diversity (Campbell
& Tishkoff, 2008), due to geographic and ethnic diversity alongside with long and short migrations,
ancient and recent population expansion which have led to complex demographic history (Sirugo et al.,
2008) alongside with having highest per capita health burden reported by the (WHO)(Castaño et al.,
2011).
It is essential to provide a better understanding of African populations in all the field of genetics and
genomic, to learn the ethnic diversity of African populations, as it will help to a better understanding
of the genetic basis of phenotypic adaptations and complex diseases and reconstruct human evolution
history (Campbell & Tishkoff, 2008). It is also important to develop bioinformatics tools that are able to
analyses the complexity of African genetics variations, as well as devolving an African specific reference
panel. These concerns are shared with the Human Heredity and Health in Africa (H3Africa) consortium.
Moreover, genomic projects such as the 1000 Human Genome Project, HapMap and The African
Genome Variation Project (AGVP) have revealed genetics insights of African populations, for instance,
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the high level of genetic variations accompanied with low and more divergent of level linkage dise-
quilibrium (LD). Compare to other populations, African populations show more complex patterns of
population substructure and the highest variant site per genome (C. N. Rotimi et al., 2017). Equally
important to these variations, it is necessary to investigate and return medically relevant pathogenic
variants known as actionable genes as recommended recently by The American College of Medical
Genetics and Genomics (ACMG). Given these challenges to pinpoint African populations specific
variants and return actionable genes associated with diseases in Africa, many questions have arisen
such as “how researchers can improve the detection of these variations ? “ Here, we attempt to answer
this, therefore, we will focus on the steps of the downstream analysis of NGS, mainly the variants
calling step, alongside the mutation prediction and annotations as shown in (Figure 1.1).
Variant calling (VC) is one of the important fundamental steps in the downstream analysis of NGS
(see Figure 1.1), it is important to ensure calling the true positive variants, in addition, to discover
true mutations and improving the clinical diagnosis. In the recent few years, many variant calling
tools have been developed, they vary in their calling algorithm, and wither they call somatic variant or
germline variants as discussed in chapter 1 .
In this chapter, we the most known and open-source variant calling tools, which are (VarScan2,
SAMtools, GATK-HaplotypeCaller , SNVer, BCFtools, FreeBayers, Lofreq, PlatyPus and VarDict) see
(Table 3.1), we excluded other variant calling tools as we follow (Sandmann, De Graaf, et al., 2017)
exclusion criteria which is either they are using same tool or they required matched sample or calling
Indels. we also excluded somatic variants calling tools.
3.2 Characteristics and Specifications of Variant Calling
tools
After the simulation, we used the generated data for reading alignment, and various quality control
(QC) steps as Subsequent the simulation process, we align the synthetic Fastq reads to a reference
genome, and preformed post-alignment process to ensure the resulted BAM file is good and ready to be
called. As discussed in the literature review chapter, many studies have recommended various variant
calling tools to use, as demonstrated in (Table 1.1). Henceforth, we have chosen nine variant calling
tools to use in this downstream analysis to conclude which tools have the most accurate call with a low
rate of FP and FN and work best on the African population variations.Here we are introducing the most
known and open-source variant calling tools, which are (VarScan2, SAMtools, GATK-HaplotypeCaller,
SNVer, BCFtools, FreeBayers, Lofreq, PlatyPus and VarDict), we excluded other variant calling tools
as we follow (Sandmann, De Graaf, et al., 2017) exclusion criteria which is either they are using the
same tool, or they required matched sample or calling Indels. Here an overview of the tools arranged
by releasing date:
1. VarScan2: In 2009 koboldt et al., introduce VarScan (Koboldt et al., 2009) to detect SNPs and
Indels, as they stated that VarScan is an open-source tool unlike the tools before and compatible
with several read aligners. In 2012, the same developers updated the tool to VarScan2, in order
to further detect somatic (acquired) mutations and copy number alterations CNAs in cancer by
exome sequencing. They used both known variants calling algorithms heuristic and statistical,
additionally, they used correlation matrix diagonal segmentation CMDS algorithms to identified
CNAs/CNVs (Koboldt et al., 2012).
2. Samtools: the most used and popular variant calling tools are: SAMtools (H. Li et al., 2009),
which can preform multiple tasks see (Table 3.1). The Samtools package consists of two different
variant calling tools Samtools and BCFtools http://github.com/samtools/samtools.
3. GATK-HaplotypeCaller: that have a robust performance and features such as coverage
analysis, quality score recalibrations to eliminate FP variants and other reads data manipulations.
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It can also detect both germline and somatic variants https://software.broadinstitute.org/
gatk/.
4. SNVer: In 2011, SNVer developers (Wei et al., 2011) motivated to call the variant in a pooled
sequencing, since it was a need back then to both improve the computational cost and accuracy.
They also call individuals NGS data and other features. It applies hypothesis testing problem and
uses the binomial- binomial model to analyse the pooled or individual NGS data. It allows users
to choose FP error rate. When compared to GATK and SNVer, it has the same performance, but
since pooled sequenced has advantage of leveraging haplotypes patterns, thus SNVer preformed
best according to (Wei et al., 2011) .
5. BCFtools: implement SAMtools pileup but with new methods as described in (Table 3.1). The
difference is that BCFtools introduced multiallelic calling model, while Samtools uses consensus
calling model (H. Li et al., 2009; H. Li, 2011) https://github.com/samtools/bcftools.
6. FreeBayers: (Garrison & Marth, 2012) developed a haplotyped based variant director and
can also detect multiallelic loci with non-uniform copy numbesr.
7. Lofreq: Since calling variant in low frequency is a challenging step, Lofreq (Wilm et al., 2012)
were developed to detect rare and true variation with frequencies lower than the average error
rate.
8. PlatyPus: (Rimmer et al., 2016) introduced Platypus with developed assembly algorithms
which cope with highly divergent region (Table 3.1).
9. VarDict: The last variant calling tool will be reviewed is VerDict (Lai et al., 2016), designed
to call complex variants and actionable mutations in cancer research. Table 3.1 provides these
listed variant calling tools use-abilities and limitations. Further, Table 3.1 also provides the
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3.3 Materials and Methods
3.3.1 Data Description
We have used the generated simulated data from Chapter 2 also showed in (Table 3.2). In fact,
two population-specific simulated data sets at two depth coverage (high and low) each set represent
African and European population, respectively are considered for variant calling, therefore a total of
4 data sets (AFR high, AFR low, EUR high and EUR low) as described in Chapter 2. These data
was generated from NEAT-genReads. We set the sequencing error rate at 0.1 as it represents the
illumina sequencing platform error rate. Since most of the NGS downstream analysis tools has been
performed using European data (Campbell & Tishkoff, 2008), therefore, we compare African and
European populations, to observe if the variant calling tools handle the complex variations presented
in the African populations, as well as they, handle the European data.
Table 3.2: Data generated by NEAT-genReads, used to analyse the performance
of variant calling tools.
African Populations European Populations
Coverage Depth High Low High Low
(30- 50x) (20 -10x) (30- 50x) (20- 10x)
Sequencer illumina illlumina
Sequencing Error rate 0.1 0.1
Sample numbers 25 25 25 25
Total 50 50
3.3.2 Data Generation and Processing
Given the output results from NEAT-genReads in three different forms: (1) forward and reverse FastQ
file, (2) golden BAM, and (3) golden VCF, We have used the forward and reverse FastQ files for further
analysis, we have performed Quality control on FastQ files as illustrated in Chapter 2. Figure 3.1
illustrates the variant calling analysis pipeline that we will in subsequent sections below.
Figure 3.1: Overview of the variant calling analysis pipeline.
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Reads Alignment and Mapping to Reference Genome
We align forward and reverse FastQ to the latest human reference genome hg38/GRCh38 by using
BWA mem alignment tool developed by (H. Li, 2013), resulted in SAM files.
Post-Alignment Process
First, we replaced the reading group in the SAM file by using Picard (AddOrReplaceReadGroups),
as the simulation tool generated one @RG tag for all the generated data, which will not be accepted
by GATK and other VC tools, as the reading group must be unique for each sample. Second, we
sorted SAMfile and generated BAM files by using Picard (SortSam). Finally, we indexed BAM
by Picard (BuildBamIndex). Now the BAM files are ready to be called and used as an input for
variant calling tools. Picard (Broad Institute, (Accessed: 2018/02/21; version 2.17.8)) available at
http://broadinstitute.github.io/picard/. To not penalise VC tools that can be sensitive to
post-alignment quality control and of course since the data used are simulated, we opted to not conduct
further post-alignment quality control such as mark duplication, realignment around indels.
3.3.3 Performing Variant Calling
After the post-alignment step, the resulted BAM file was used as an input for each of the nine variant
calling tools listed in (Table 3.3). All 100 BAM samples were used. We joint call all the samples for
SAMtools, BCFtools, FreeBayes, SNVer, GATK, Platypus and VarScan, but, we couldn’t apply it on
Lofreq and Vardict as they are designed to call per sample.
Table 3.3: List of the variant calling tools used to detect SNPs from simulated
WGS data.
Year Tool Version URL Ref
2009 VarScan2 2.3 http://varscan.sourceforge.net (Koboldt et al., 2009,
2012)
2009 Samtools 1.6 http://github.com/samtools/
samtools





(McKenna et al., 2010)









https://github.com/ekg/freebayes (Garrison & Marth,
2012)
2012 Lofreq 2.1.2 https://csb5.github.io/lofreq/ (Wilm et al., 2012)
2016 PlatyPus 0.7.9.1 https://www.well.ox.ac.uk/
platypus
(Rimmer et al., 2016)
2016 VarDict 1.70 https://github.com/AstraZeneca
-NGS/VarDict
(Lai et al., 2016)
Variant calling parameters
We set the parameters to call from chr1- chr22 only, and if the tool support frequency-based calls
such as VarDict and freebayes, we set the rate to 0.01 as the minimum allele frequency. We called the
variants simultaneously across all BAM files, and this is known as joint calling and produce one VCF
files for each caller, except Vardict, Lofreq per sample-based call was conducted .
Variant calling performance measures and analysis
We compared the VC tools by variant positions using a custom python script to extract variant position
from each resulting VCF files, and we computed key measuring performance include True Positive
(TP), False Positive (FP) and False Negative(FN). Furthermore, we calculated the performance as
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explained in Section 1.9, sensitivity (Recall) in Equation 1.3, precision (PPV) as in Equation 1.4 and
F-score as in Equations 1.6. While the Ti/Tv were obtained from using Bcftools-stat. We visualise
the intersection of variants simulated versus those in golden VCF by using Intervene tool by (Khan &
Mathelier, 2017).
3.4 Results
The variant calling was performed by VarScan, Samtools, GATK-HC, SNVer, Bcftools, FreeBayes,
Lofreq, Platypus and Vardict on simulated data (African and European) resulted from NEAT as
described in Chapter 2. We divided the simulated data as four sets: (1) African population- High
coverage data, (2) African population- Low coverage data, (3) European population- High coverage
data (4) European population- Low coverage data as shown in (Table 3.2). All resulted VCFs was
compared against Golden VCF produced from NEAT.
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Table 3.4: Summary of the performance metric regarding eight variant calling
tools evaluated from simulated data representing African and European
Population.
The samples represent simulated data of different coverages. True Positive (TP), False Positive
(FP) and False Negative were used to calculate the performance metric of each variant calling
tool.
African Population
Cov* Caller TP FP FN Recall PPV* F-score Ti/Tv
High
VarScan 481,237,109 4,202,307 115,279,037 0.2945 0.991 0.454 1.67
Samtools 936,138,549 4,801,172 697,888,931 0.572 0.994 0.727 1.73
GATK-HC 1431,790,559 480,655,083 202,236,921 0.876 0.748 0.807 1.70
SNVer 1,042,052,763 217,963,522 59,197,4717 0.637 0.827 0.720 1.67
Bcftools 86,766,719 1,593 154,726,0761 0.053 0.999 0.1008 1.73
Lofreq 1403,439,343 23,030,134 230,588,137 0.858 0.983 0.917 1.76
PlatyPus 163,693,637 206,728 1,470,333,843 0.1001 0.998 0.182 2.80
VarDict 8,462,928 59 1,625,564,552 0.0051 0.999 0.010 1.67
Low
VarScan 46,079,2497 69,094,327 1,258,564,680 0.268 0.869 0.409 1.68
Samtools 103,3862,412 2,922,554 685,494,765 0.6013 0.997 0.750 1.73
GATK-HC 1,392,111,583 372,576,395 327,245,594 0.809 0.788 0.799 1.71
SNVer 1,308,522,590 327,072,554 410,834,587 0.761 0.800 0.780 1.66
Bcftools 64,417,446 22,509 1,654,939,731 0.037 0.999 0.072 1.73
Lofreq 1,342,828,800 56,340 376,528,377 0.781 0.999 0.877 1.76
PlatyPus 99,883,347 73,530,996 1,619,473,830 0.0580 0.575 0.105 2.43
VarDict 8,100,636 36 1,711,256,541 0.004 0.999 0.009 1.66
European Population
Cov* Caller TP FP FN Recall PPV* F-score Ti/Tv
High
VarScan 395,900,288 60,684,867 1,276,091,292 0.236 0.867 0.371 1.54
Samtools 977,511,680 2,238,536 694,479,900 0.584 0.997 0.737 1.59
GATK-HC 1,488,460,421 552,553,957 183,531,159 0.890 0.729 0.8017 1.56
SNVer 1,017,864,538 207,333,783 654,127,042 0.608 0.830 0.702 1.54
Bcftools 50,923,622 1,363 1,621,067,958 0.0304 0.999 0.059 1.59
Lofreq 1,368,140,684 73,175 303,850,896 0.818 0.999 0.900 1.63
PlatyPus 180,556,949 144,184 1491,434,631 0.107 0.999 0.194 2.39
VarDict 7,881,251 46 1,664,110,329 0.004 0.999 0.009 1.55
Low
VarScan 484110062 69838149 1222614957 0.283 0.873 0.4282 1.55
Samtools 325,017,774 8,279 1,381,707,245 0.190 0.999 0.319 1.60
GATK-HC 691,478,420 111,097,346 1,015,246,599 0.405 0.861 0.551 1.56
SNVer 1,421,204,610 454,469,916 285,520,409 0.832 0.757 0.793 1.54
Bcftools 700,731,299 169,5148 1,005,993,720 0.410 0.997 0.581 1.59
Lofreq 1,344,126,496 47,249 362,598,523 0.787 0.999 0.881 1.63
PlatyPus 164,588,476 160,790 1,542,136,543 0.096 0.999 0.175 2.23
VarDict 7,955,439 48 1,698,769,580 0.004 0.999 0.009 1.54
*PPV=Positive Predictive Value, Cov=Coverage
As shown in Table 3.4, we were able to calculate TP, FP and other metric performance
measures : The first data set (golden AFR - high) , the African Golden - high coverage
vcf (truth set) contains 1, 634, 027, 480 SNPs as a total for all the 25 samples, GATK-HC and
Lofreq have the highest TP among all result with (sens= 0.87), (sens=0.85) respectively. Since
GATK had the highest sensitivity it goes with low PPV (PPV=0.7), all variant calling tools
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have good precision, however Vardict achieved the highest with very low FP (PPV=0.999), see
(Table 3.4). Finally, F-score, which measures the overall performance, indicates that Lofreq
had the highest performance among all (F-score=0.91) followed by GATK-HC (F-score=0.80).
The second data set (AFR - low): By the same token GATK-HC had the highest TP
among all other tools, the AFR-low Golden vcf contains 1, 719, 357, 177 SNPs, and Vardict had
the lowest FP with high precision (PPV=0.999), and Lofreq had the high F-score (F-score=0.87),
see (Table 3.4).
The third data set (EUR - high) Golden vcf contains 1, 671, 991, 580 true SNPs, GATK
has the highest FP (sens=0.89) followed by Lofreq (sens=0.81) and high F-score (F-score=0.90),
all tools had good PPV (Table 3.4).
The fourth data set (EUR - low) , SNVer had the highest TP among all tools (sens=0.82),
and Lofreq with high (F-score=0.88), all tools had good PPV (Table 3.4). If the Ti/Tv ratio is
too low, it is more likely to have false positive. The ratio among all is good, but Platypus had
the highest ratio among all in the four data sets, indicating that Platypus tends to infer high
rate of false positive variants during the call. Of note, Vardict has a great deal in generating
less false positive variant discovery and seems to perform much better in African simulated data
sets. In contrast, we weren’t able to analyse Freebayes result as the output vcf files have no
variant positions.
Regarding sequence depth, the result shows a higher number of calls for high coverage and
vice versa, see Table 3.4 and Figure 3.2. The overall result of each variant calling tools are a
bit similar for both European and African populations, GATK-HC, Lofreq, SNVer and Samtools
has the lowest FN among all, while Vardict, Bcftools, Lofreq and Samtools has the lowest
FP among all, and regarding TPs, the highest result are from GATK-HC, Lofreq, SNVer and
Samtools. Concerning, CPU wall-time, almost all variant calling tools took a very long time, we
had to use multithreading and GNU Parallel (Tange, 2011), to process data in parallel and to
reduce run time. GATK-HC took very long CPU wall-time.
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Figure 3.2: Relation between Positive Predictive Value (PPV) and Sensitivity in





















































































Figure 3.3: An UpSetR diagram visualising the intersections of the variant positions produced by Samtools, BCFtools,
SNVer, GATK , Platypus, VarScan, Lofreq and Vardict, on African population- High coverage data.
The red top bar-plot illustrates the size of the intersection, the linked points below display the intersecting sets of variants, while the blue





















































































Figure 3.4: An UpSetR diagram visualising the intersections of the variant positions produced by Samtools, BCFtools,
SNVer, GATK , Platypus, VarScan, Lofreq and Vardict, on European population- High coverage data.
The red top bar-plot illustrates the size of the intersection, the linked points below display the intersecting sets of variants, while the blue





















































































Figure 3.5: An UpSetR diagram visualising the intersections of the variant positions produced by Samtools, BCFtools,
SNVer, GATK , Platypus, VarScan, Lofreq and Vardict, on African population- Low coverage data.
The red top bar-plot illustrates the size of the intersection, the linked points below display the intersecting sets of variants, while the blue





















































































Figure 3.6: An UpSetR diagram visualising the intersections of the variant positions produced by Samtools, BCFtools,
SNVer, GATK , Platypus, VarScan, Lofreq and Vardict, on European population- Low coverage data.
The red top bar-plot illustrates the size of the intersection, the linked points below display the intersecting sets of variants, while the blue
bar-plot on the bottom left shows the set size of each tool.
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3.5 Discussion and Overall Chapter Summary
The tremendous development of Next-Generation sequencing has promoted the evolution of
personalised medicine. Such progress in NGS resulted in an enlargement of the downstream
analysis tools to handle such data. Such an example, many variant calling tools have been
developed, which raise the question of which tool one can choose when dealing with a complex
and diverse genome such as the African genome? In this chapter, we were able to answer this
question. We compare nine variant calling tools (VarScan2, SAMtools, GATK-HaplotypeCaller,
SNVer, BCFtools, FreeBayers, Lofreq, PlatyPus and VarDict) on simulated data representing
two population (African and European) at varying coverage (high and low) as a total of 4
data sets. We assessed these tools based on sensitivity and precision and most importantly,
the F-score to measure the overall performance, low sensitivity and precision result in low
F-score.An increased specificity may result in the loss of true positive data while a prioritised
sensitivity will result in increased false positive data. Depending on the desired output for
a study, sensitivity or specificity must be favored as there is a trade-off between these two.
The total average of FPs for the African population at different coverage (= 98508519, 31)
are a bit higher than the European populations (= 91271677, 25); hence the ability of variant
calling tools to detect true variants are higher when dealing with European population which
support the previous researches done by honour students at UCT Noëlle van Biljon,2017 and
Loratoeng Mpolokeng,2018, that many tools are suitable when dealing with European data
than African. Here we discuss the performance of each tool on the four data sets (AFR-high,
AFR-low, EUR-High and EUR-Low):
1. VarScan2: the result for the first data set was (sens=0.29), (PPV=0.99) and (F-
score=0.45).
2. Samtools: Performed well with low FPs (PPV=0.99) for all data sets.
3. Bcftools: unlike excepted it has the lowest performance among all tools, it may be due
to Bcftools-Concat stages when we merged the 22 vcf into one, it could be led to losing
some lines resulted in low variant positions.
4. GATK-HaplotypeCaller: showed the highest TPs in both coverages for the African
population, accompanied by high F-score. From our analysis, when considering sensitivity
GATK-HC performed best on both African and European populations.
5. SNVer: output two vcf files, one are SNPs call without filtering process, and the other
contains Indel calls, the metric results are good with high sensitivity and precision for all
four data sets as shown in (Table 3.4).
6. FreeBayers: detected variants for the (AFR-High = 109, 317, 033), (AFR-Low =159, 320, 395),
(EUR-High =127, 301, 186) and (EUR-Low = 175, 720, 958) but all without base-pair posi-
tions, for this reason we excluded it from comparison.
7. Lofreq: showed remarkably good results, F-score for all data sets are the highest among
all results alongside with Sensitivity (Recall) and Precision (PPV), especially with the
African-high coverage data set. Figure 3.2 illustrates the relationship between Positive
Predictive Value (PPV) and Sensitivity regarding different coverage, Lofreq in colour
purple shows great performance. Figures 3.3, 3.4, 3.5 and 3.6 show the very large
intersection of variants between Lofreq and Golden vcf (Truth set) only.
8. PlatyPus: result are good regarding Precision (PPV=0.9) and (Ti/Tv=∼ 2.4 ) for all
4 data sets.
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9. VarDict: From the first run of Vardict, we used a bed file contain all regions of
interest. This took very large number of CPUs and exceeded wall time specified by High
Performance Computing. The larger the bed file, the longer it took to be processed and
done. Therefore, we repeated calling on smaller bed file based on autosomal chromosomes
(1 to 22), hence, larger variants were missing. This may affect the result with very high
False Negative as it may be missing variants that are not called by Vardict and absent
in golden VCF file. Furthermore, Vardict uses post-processed step depending on R and
Perl script, R works very slowly as it calculates Fisher’s exact test and odds ratio, which
took a very long time to process. The metric result of Vardict was good in case of true
positive as almost all the variants that are detected are considered to be True positive,
the total variants of African-High coverage that are called from Vardict are 8, 462, 987,
and the true positive are 8, 462, 928 (PPV=0.999). VarDict can be suggested for African
targeted sequence data.
In summary, higher sequence depths helps variant calling tools to be more confidently call the
true variant, this confirms and supports previous findings (Huang et al., 2015). Considering
both sensitivity and PPV, Lofreq outperformed all VC tools. It can accurately call such a
complex and large variants with high TPs and low FPs even at very low frequency. Our finding
support (Huang et al., 2015) result. Our current results suggest that Lofreq can currently be
a great option in calling WGS from African populations and VarDict can be considered for
targeted sequence, particularly for African data. Moreover, some of the high genetics variations
presented in the result may could be artefacts; as a result, it is essential to apply multi variant
calling tools to ensure calling true variants. Given huge amount of non-overlapped variants
across the results from current VC tools and differing number of variants discovered across these
tools, it will be reasonable to consider multi variant calling tools to allow cross validation of
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4.1 Introduction
The NGS sequencing analysis contributed to the improvement of patient and clinical care. This
development has hoped to bridge the gap between healthcare and genomics. Furthermore, as
mentioned earlier, variant calling is an important aspect of genomics studies as polymorphism
information can be used to influence the discovery of actionable pathogenic variants and therefore
important clinical decisions. Currently, the definition of actionable pathogenic variants varies
among scholars.
The Clinical Genome Resource (ClinGen) presents actionability as clinically prescribed
interventions to a genetic disorder that is effective for prevention or lowered clinical burden
or delay for a clinical disease or improved clinical treatments and outcomes in a previously
undiagnosed adult (Hunter et al., 2016). On the other hand, 100,000 Genomes Project protocol
presents actionable genes as variants that can significantly prevent (or result in illness or
disability that is clinically significant, severely life threatening and clinically actionable) disease
morbidity and mortality, if identified before symptoms become apparent. However, in any cases
the classification of variants to be clinically actionable or not dependent and can only emerge
during the process of seeking ethical approval for the study (Caulfield et al., 2017).
Overall, in current literature and most annotation databases, the classification of pathogenic-
ity differs (Sherry et al., 2001; K. Wang et al., 2010; Z. Wang, Liu, Yang, & Gelernter, 2013;
Landrum et al., 2016; McLaren et al., 2016). To illustrate this, study conducted by (Dorschner
et al., 2013) leveraged exome data of European and African diaspora to dissect actionable
pathogenic variants, however their findings suggested that actionable pathogenic variants were
disproportionate between European and African descent with an estimated frequency of ap-
proximately 3.4% and 1.2%, respectively. This indicates deficit of identification of pathogenic
variant in African population in general. Furthermore, this illustrates a deficit of identification
of pathogenic variant in African population in general. A similar study by (Amendola et al.,
2015) also confirmed the findings of (Dorschner et al., 2013).
Nevertheless, a common feature to define actionability is to combine many annotation
pipelines during filtering and prioritisation mutations, in which casting vote can be applied
respectively to allow better prediction of the targeted variant. Furthermore, on top of ethical
approval, the ancestral/derived minor allele frequency of the variants, segregation evidence, and
the number of the patients affected with the variants and their status as a de novo mutation
can highly be considered.
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In this chapter, we provide a broad assessment of possible actionability of variants known to
be associated to top four burden African diseases and a list of actionable genes from American
College of Medical Genetics and Genomics (ACMG) using WGS data of 20 world-wide ethnic
groups. In doing so, we aim to
1. apply the best variant calling tool identified in previous chapter 3 on publicly available data,
the African Genome Variation and 1000 Genome Project and examine the evolutionary
variation of pathogenic mutation based on selected known disease-genes from four big
African burden diseases include HIV/AIDS, Malaria, Tuberculosis (TB), Sickle cell disease
and a set of known actionable genes across 20 world-wide population ethic groups.
2. perform disease-genes population structure from these known disease-genes (HIV/AIDS,
Malaria, Tuberculosis (TB), Sickle cell disease and a set of known actionable genes) among
20 world-wide ethnic-specific data.
3. examine the heterozygosity ratio, the proportion of ancestral/derived alleles, and the dis-
tribution of minor allele frequencies based on these selected disease-genes from HIV/AIDS,
Malaria, Tuberculosis (TB), Sickle cell disease and a set of known actionable genes across
20 world-wide ethnic-specific data.
4.2 Methods and Material
4.2.1 Data Description and Quality Check
We accessed bam files from 1000 Genomes Project (1KGP) (Consortium et al., 2012) and
the African Genome Variation Project (AGVP) (Gurdasani et al., 2015), which has recently
characterised the admixture across 18 ethno-linguistic groups from sub-Saharan Africa as shown
in (Table 4.1). A quality control check was conducted these bam files using samtool. We
finally retain 2,504 bam files from 1000 Genomes Project and 2,428 bam files from AGVP, a
total of 4,932 samples. Based on the initial sample description including population or country
labels, we grouped samples ( Table 4.1) based on the ethno-linguistic information obtained
from (Gudykunst & Schmidt, 1987; Michalopoulos, 2012).
Table 4.1: Data obtained from 1000 Genomes Project (1KGP) (Consortium et al.,
2012) and the African Genome Variation Project (AGVP) (Gurdasani et al.,
2015) and used for analysis.
Population
label
Ethnic group Population description Samples
ID.
AFR
Afro Asiatic Semitic Amhara:Ethiopia 22
African American Americans of African Ancestry in SW USA
(ASW)
60
African Caribbean African Caribbeans in Barbado (ACB) 96
Afro Asiatic Al-Gharbiyah, NA, Monufia, Kafrel-Sheikh,
Mansoura, Alexandria, Dakahlia, Samanoud,
Al-Buhayrah, Minya, AlSharqia, El-Mahalla all
from Egypt
99
Afro Asiatic Cushitic Oromo, Somali from Ethiopia 47
Afro Asiatic Omotic Wolayta from Ethiopia 24
Khoe-San Khoe-San:Khoesan 84
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Table 4.1 – Continued from previous page
Population
label
Ethnic group Population description Samples
ID.
Niger Congo Bantu Baganda, Banyarwanda, Barundi, RwandeseU-
gandan, Banyankole:Uganda Bakiga, Mutan-
zania, Basoga, other uganda gwas unknown,
Mutooro, Batooro, Nyanjiro (Tanzania) from







Esan in Nigeria (ESN), Yoruba in Ibadan,
Nigeria (YRI)
205
Niger Congo West Gambian in Western Divisions in the Gambia
(GWD), Mende in Sierra Leone (MSL)
198
AMR Latin American Puerto Ricans from Puerto Rico (PUR),
Colombians from Medellin, Colombia (CLM),
Peruvians from Lima, Peru (PEL), Mexican
Ancestry from Los Angeles USA (MXL)
347
EAS East Asian Southern Han Chinese (CHS), Chinese Dai
in Xishuangbanna, China (CDX), Kinh in Ho
Chi Minh City, Vietnam (KHV), Han Chinese




European center British in England and Scotland (GBR) 91
European North Finnish in Finland (FIN) 99
European South Iberian Population in Spain (IBS), Toscani in
Italia (TSI)
214




South Asian Punjabi from Lahore, Pakistan (PJL), Bengali
from Bangladesh (BEB)
180
UK Indian Sri Lankan Tamil from the UK (STU), Indian
Telugu from the UK (ITU)
204
USA Indian Gujarati Indian from Houston, Texas (GIH) 103
Total 4,932
AFR: African, SAS:South Asian, AMR:Ad Mixed American, EUR:European, EAS:East Asian
4.2.2 Variants Discovery Analysis
As per our result from the evaluation of various variant calling tools (Chapter 3), we adopted Lofreq
to conduct joint call across 2,504 samples from 1000 Genomes Project and 2,428 from AGVP for a
total of 4,932 samples in 20 world-wide ethnic groups. The best practice specific to Lofreq caller was
adopted, the resulting variant sets of all 4,932 samples in VCF file were filtered using the Samtool tool.
We added additional filter levels as follows: If 3 SNPs are detected within a window of 10 base-pairs,
the site will be flagged as a “SNPCluster” in the FILTER column. If 4 or more alignments having a
mapping quality of MQ = 0 (which means it maps to different locations equally well) and the number of
alignments that mapped ambiguously are more than a tenth of all alignments, it is difficult to decipher
artefacts and true differences. These sites will be flagged as “HARD TO VALIDATE”. SNPs which are
covered by less than 5 reads may be potential artefacts and these sites were flagged as “LowCoverage”,
SNPs having a SNP quality below 30 are typically artefacts, were flagged as “VeryLowQual”, SNPs
having a quality score between 30 and 50 are potential artefacts, flagged as “LowQual”, SNPs having a
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QD score ¡ 1.5 are indicative of false-positive calls and artefacts, flagged as “LowQD” and SNPs covered
only by sequences on the same strand are often artefacts, was flagged as “StrandBias”. Variants flagged
“VeryLowQual”, “LowQual”, “LowQD” and “StrandBias” were removed in VCF file. The resulting
VCF file contained 4,932 samples.
4.2.3 Variant Annotation
The resulting joint call VCF file contained 4,932 samples and samples were split into 20 VCF files per
ethnic group as listed in (Table 4.1), and we used ANNOVAR (K. Wang et al., 2010) to independently
perform gene-based annotation in each final VCF data set to determine whether SNPs cause protein-
coding changes and produce a list of the amino acids that are affected. We used ANNOVAR settings,
where the population frequency, pathogenicity for each variant was obtained from 1000 Genomes
exome21, Exome Aggregation Consortium30 (ExAC), targeted exon datasets and COSMIC31.
Gene functions were obtained from RefGene32 and different functional predictions were obtained
from ANNOVAR’s library, which contains up to 21 different functional scores including SIFT33,34,
LRT35, MutationTaster36, MutationAssessor37,38, FATHMM39, fathmm-MKL39, RadialSVM40,
LR40, PROVEAN40, MetaSVM40, MetaLR40, CADD41, GERP++42, DANN29, M-CAP29, Eigen29,
GenoCanyon29, Polyphen2 HVAR43, Polyphen2 HDIV43, PhyloP44 and SiPhy44.
We additionally included conservative and segmental duplication sites, dbSNP code and clinical
relevance reported in dbSNP45. From each resulting functional annotated data set, we independently
filtered for predicted functional status (of which each predicted functional status is of ”deleterious”(D),
”probably damaging” (D), ”disease causing automatic” (A) or ”disease causing” (D).46,47,49) from
from SIFT (Ng & Henikoff, 2003), LRT (Chun & Fay, 2009), MutationTaster (Schwarz et al., 2010),
MutationAssessor (Reva et al., 2011), FATHMM (Shihab et al., 2013), FATHMM-MKL (Shihab et al.,
2013), RadialSVM (Liu, 2014), LR (Agresti, 2012), PROVEAN (Choi & Chan, 2015), MetaSVM (Kim,
Jhong, Lee, & Koo, 2017), MetaLR (Dong et al., 2014), CADD (Rentzsch et al., 2018), GERP++
(Davydov et al., 2010), DANN (Quang, Chen, & Xie, 2014), M-CAP (Jagadeesh et al., 2016), Eigen
(Ionita-Laza, McCallum, Xu, & Buxbaum, 2016), GenoCanyon (Lu et al., 2015), Polyphen2-HVAR
(Adzhubei et al., 2010), Polyphen2-HDIV (Adzhubei et al., 2010), PhyloP (Doerks, Copley, Schultz,
Ponting, & Bork, 2002), and SiPhy (Garber et al., 2009).
We used a casting vote approach implemented in our custom python script, to retaining only a variant
if it had at least 17 predicted functional status “D” or “A“out of 21. Second, the retained variants
from each data set were further filtered for rarity, exonic variants, and nonsynonymous mutations and
with a high-quality call as described above, yielding a final candidate list of predicted mutant variants
in each subject group, including the replication group. We report on the aggregated SiPhy score from
all identified mutants SNPs within the gene. Sections below provide details on how SNPs were mapped
to genes.
4.2.4 Phased and Haplotypes Inference
To increase the accuracy, the resulting VCF file contained 4,932 samples of 20 ethnic groups, were
used to further conduct quality control in removing all structured, indel, multi-allelic variants and
those with low minor allele frequency (MAF < 0.05) prior to phasing. We first phased and inferred
the haplotypes using Eagle software https://data.broadinstitute.org/alkesgroup/Eagl from the
resulting curated data. We further compared sites discordance between these haplotype panels and
independently with their original VCF file prior phasing. The only site with phase switch-errors showed
discrepancies in MAF and were therefore removed. The whole phased data contained 4,932 samples of
20 ethnic groups were used to conduct downstream analysis below.
4.2.5 Disease- and Actionable Gene-specific Population Structure
We obtained list of genes known as medically actionable from https://www.fredhutch.org/en/news/
releases/2014/09/actionable-genome-consortium-world-renowned-cancer-institutions.html,
and Actionable Genome Consortium (ACG) and also we collect from GWAS Catalog https://www.ebi
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.ac.uk/gwas/, literature and gene-diseases database such DisGeNET http://www.disgenet.org/
list of genes associated with four major African diseases including Malaria, TB, HIV and Sickle cell
disease. We obtained 50, 77, 460, 75 and 114 genes known to associate with Tuberculosis, Malaria,
Sickle Cell Anemia, HIV and ACG, respectively. We leveraged the dbSNP database to extract SNPs
associated with these genes per diseases, as shown in (Table 4.2). The obtained SNPs per disease were
thus extracted from the whole phased data contained 4,932 samples of these 20 ethnic groups; yield 5
disease-specific phased haplotypes data sets Table 4.2.
Table 4.2: The Number of SNPs after Quality Control (QC) in each group of







To evaluate the extent of substructure within disease-specific polymorphism across world-wide
ethnic groups, we leverage each constructed disease-specific phased haplotypes data set, to perform
genetic structure analysis based on Principal Component Analysis (PCA) using smartpca, part of the
EIGENSOFT 3.0 package (Patterson, Price, & Reich, 2006). The PCA plot was obtained from using
genesishttp://www.bioinf.wits.ac.za/software/genesis.
4.2.6 Proportion of Ancestral/Derived Alleles among Risk confer-
ring Alleles
Each of these four disease-specific phased haplotypes data sets were used to analyse the fraction of
derived and ancestral alleles at-risk allele within each ethnic group. Previous work has shown that
derived alleles are more often minor alleles ( < 50% allele frequency) and more often associated with
risk than ancestral alleles (Gorlova et al., 2012). Therefore, we define risk allele as follow, if gene is
being reported to increase the risk of disease (Odd ratio > 1)from either DisGeNET or GWAS Catalog,
risk allele were defined as minor allele (for all SNPs associated to the gene) otherwise (Odd ratio < 1)
is defined as major allele (for all SNPs associated to the gene).
We downloaded the SNP ancestral alleles from the Ensembl, a 59 comparative 32 species alignment
(Paten et al., 2008), and we further checked the SNPs for those present in the dbSNP database. Each
of these four disease-specific phased haplotypes data sets was further annotated using the VCFtools
‘fillOaa’ script (Danecek et al., 2011) with the ancestral allele recorded using the ‘AA’ INFO tag
(McVean et al., 2012).
For each disease-specific data set, we determined the proportion of risk alleles that were ancestral or
derived allele. We first computed, for each SNP, the fraction of ancestral allele, which was calculated
by dividing the number of times the defined risk allele matched with ancestral allele by the total
number of copies of all alternative alleles across all samples (within each ethnic group per disease) for
a particular SNP. The fraction of derived allele is equivalent to 1 minus the fraction of ancestral allele.
As mentioned earlier, derived alleles are more often minor alleles (< 50% allele frequency) and more
often associated with risk than ancestral alleles, therefore, we investigated the relationship between the
fraction of derived allele at-risk allele and ethnic group SNP minor allele frequency. To this end, the
alternative (minor) alleles were categories into 6 bins, (0− 0.05, > 0.05− 0.1, > 0.1− 0.2, > 0.2− 0.3, >
0.3− 0.4, > 0.4− 0.5)with respect to each data set frequencies and we, independently, computed the
fractions of derived alleles in each bin (above).
Furthermore, we computed the fraction of ancestral/derived alleles for all these known disease-specific
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genes. To this end, we aggregated (see section 4.2.8 below) the fraction of ancestral/derived alleles
at SNP-based level to gene, considering all SNPs located within the gene’s downstream or upstream
region (Chimusa et al., 2015).
4.2.7 Distribution of Minor Allele Frequency and Gene-specific in
SNP Frequencies
To examine the extent to how common variants across these 20 ethnic groups within a specific disease
(TB, HIV Sickle Cell Anemia and Malaria) and know actionable genes from ACG, we, therefore,
investigated the distribution of the minor allele frequency. To this end, the proportion of minor alleles
were categorised into 6 bins (0− 0.05, > 0.05− 0.1, > 0.1− 0.2, > 0.2− 0.3, > 0.3− 0.4, > 0.4− 0.5)
with respect to each ethnic group with a disease. The minor allele frequency (MAF) per SNP for
each category was computed using Plink software (Purcell et al., 2007). Furthermore, the fraction of
gene-specific in SNPs frequency for each gene was computed. To this end, the fraction of gene-specific
in SNPs frequency was computed, assuming SNPs in upstream and downstream within a gene region
are close and possibly in Linkage Disequilibrium (LD). Minor allele frequency per SNP has aggregated
a gene level (see section 4.2.8).
4.2.8 Aggregating SNPs Summary Statistics at the Gene level
From each ethnic group, we gene-specific in SNPs allele. In doing so, we aggregated SNP-specific allele
frequencies or proportion of ancestral/derived allele from SNPs 40kb downstream and upstream within
gene region as per dbSNPs database. Under the null hypothesis, frequency/proportion Pk (k =1,..., L)
with a continuous distribution, are uniformly distributed in the interval [0,1].
It follows that a parametric cumulative distribution function F can be chosen and Pk can be transformed
into quantile according to qk = F






sum of independent and identically distributed random variables Pk. To account for the independence
assumption given correlation among neighboring genomic markers, we implement the Stouffer-Liptak
method accounting for spatial correlations among SNPs within a gene or SNPs within a given sub-
network. The overall statistic can be obtained by P = Φ(Cp), in which Φ is the cumulative distribution
function of the standard normal distribution.
4.3 Results
4.3.1 Disease- and Actionable Gene-specific Population Structure
HIV variation is observed among Bantu, African-American, Khoisan and Afro-Asiatic, while European
are clustering together (Figure 4.2). Most African ethnics groups have highest HIV gene-specific
frequency (Figure 4.2), indicating and confirming that HIV infection has high incidence or prevalence
among African ethnic groups compare to other ethnic groups. As for HIV, TB variation on TB-specific
genes was observed among Bantu and Khoisan and Afro-Asiatic (Figure 4.3 ), while European are
clustering together, except North European (explaining the know high incidence of TB in Central
and North Europe). Malaria-specific world-wide ethnic groups genetics structure (Figure 4.5) shows
that African ethnic groups and African American are still separated to the rest of other ethnic groups.
UK/USA Indians and Afro-Asiatic, Latin-American and all Europeans are clustering together based
on Malaria-specific genes, justifying low prevalence and/or absence of Malaria in their geographic
regions. East/South Asians are clustering apart from African and European descend ethnic groups
clusters. While it is known that Malaria has high prevalence among African and Asian populations,
the separate cluster between them may indicate differing patterns of linkage and genetics variation at
Malaria-specific genes. As expected, and as Malaria and Sickle-Cell are genetics correlated, similar
results as for Malaria are observed with Sickle-Cell disease-specific genes (Figure 4.4).
53
CHAPTER 4. DISSECTING GENETIC MUTATIONS AND SECONDARY FINDING FROM TWENTY
WORLD-WIDE ETHNICS GROUPS
Finally, population structure on ACG-specific genes reveals that African ethnic groups, European
related ethnic groups, East-Asian, and UK/USA India and South Asian ethnic groups are separated and
clustering in three different clusters (Figure 4.1). We observed that African-American and Afro-Asian
ethics are in the convex these three clusters (Figure 4.1), justifying that they are result of admixture
these geographic ancestral populations. In addition, Latin-America are close to European and South
Asian clusters, as results of admixture, they are mainly in the convex between East-Asian, South-Asian,
European and a bit distance to African. This result justifies and indicates that the actionability of
these ACG genes may have differing effects on world-wide ethnic groups.
Figure 4.1: Principal Component Analysis (PCA) of the actionable genes, , plot
of the first and the second eigenvectors for all populations.
Figure 4.2: Principal Component Analysis (PCA) of genes associated with HIV,
plot of the first and the second eigenvectors for all populations.
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‘
Figure 4.3: Principal Component Analysis (PCA) of genes associated with
Tuberculosis, plot of the first and the second eigenvectors for all populations.
Figure 4.4: Principal Component Analysis (PCA) of genes associated with Sickle
Cell Disease, plot of the first and the second eigenvectors for all populations.
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Figure 4.5: Principal Component Analysis (PCA) of genes associated with Sickle
Cell Disease, plot of the first and the second eigenvectors for all populations.
4.3.2 Pathogenic Mutation at Polymorphisms within Disease Re-
lated Associated Genes
We observed considerable high proportion of pathogenic variants within ACG-specific genes from
non-African ethnic groups include Latin America, Afro-Asiatic European related ethnic groups (Figure
??), while few genes show high proportion of pathogenic variants in Niger-Bantu, African-American
(Figure ??). African ethnic groups include Bantu and Latin American and Afro-Asiatic have consistent
considerable high proportion of pathogenic variants at these HIV-specific genes (Figure 4.7). While
Latin American and Afro Asiatic have consistent high proportion of pathogenic variants, we observed
that Khoesan group has high proportion of pathogenic variant within TB-specific genes (Figure 4.10).
Low proportion of pathogenic variants are observed across all Malaria-specific genes in Bantu and
Afro-Asiatic and Latin American ethnic groups (Figure 4.8), however except for Toll-like receptor 9
(TLR9 ) , FREM3, IL4, ICAM-1 and Nitric oxide synthase 1 (neuronal) that Bantu ethnic groups and
Latin America have high proportion of pathogenic variants (Figure 4.8). Bantu, Afro-Asiatic and
Latin America have similar low proportion of pathogenic variants in most of Sickle-Cell Disease-specific






















































































































































































































































































































































































































Figure 4.10: The proportion of pathogenic variants within Tuberculosis-specific genes among 20 world-wide ethnic groups.
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4.3.3 Distribution of Minor Allele Frequency and Gene-specific in
SNPs Frequencies
The distribution of ACG gene-specific in SNPs frequencies in Figure 4.11 indicates that all ACG genes
have gene-specific in SNP frequencies lower than 0.4% in all ethnic groups. However, the gene-specific
in SNP frequencies from most of African ethnic groups are higher compare to those from non-African
ethnic groups, supporting potential differing effect and contribution of these actionable genes among
world-wide ethnic groups. From Figure 4.12, we observe that BTNL2,MOS, CDSN, USP18, MCM8,
OAS1, COG4, CCL3L1, HLA-G, HLA-E, STT3A, TMED2 and USP18 have HIV gene-specific in
SNPs frequencies ranging between 5% to 15% and that African ethnic groups have the highest. In
Figure 4.15, 33 genes have TB gene-specific in SNPs frequencies between 5% to 20% of which all
African ethnic groups have the most high, suggesting that these genes may harbor common effect
and contribution in TB among African ethnic groups. The distribution of Malaria gene-specific in
SNPs frequencies Figure 4.13 suggests five genes including GYPB, FCGR2A, IL13, and FREM3 with
gene-specific in SNPs frequencies ranging between 4% to 15%, while all Sickle-Cell disease related
genes in Figure 4.14 have low gene-specific in SNPs frequencies ranging between 0.1% to 0.3% among
all 20 ethnic groups, but all African and diaspora ethnic groups have the highest.
Figure 4.11: The distribution of the minor allele frequency giving a gene level
(Actionable Genes) among all ethnic groups.
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Figure 4.12: The distribution of the minor allele frequency giving a gene level
(HIV) among all ethnic groups.
Figure 4.13: The distribution of the minor allele frequency giving a gene level
(Malaria) among all ethnic groups.
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Figure 4.14: The distribution of the minor allele frequency giving a gene level
(Sickle Cell Disease) among all ethnic groups.
Figure 4.15: The distribution of the minor allele frequency giving a gene level
(Tuberculosis) among all ethnic groups.
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4.3.4 Gene-specific in Derived Allele Proportion and Relationship
between Derived and Ethic-specific Minor Allele
Derived alleles are more often minor alleles ( < 50% allele frequency) and more often associated with
risk than ancestral alleles (Gorlova et al., 2012). Our results show high proportion of derived allele
at low ethnic-specific minor allele frequency (ranging between 0.0 to 0.1), showing high variation in
proportion of derived allele in TB (Figure 4.20), HIV (Figure 4.17), Malaria (Figure 4.18), Sick-Cell
Disease (Figure 4.19) and set of actionable genes (Figure 4.16) across all African ethnics compare
to the rest of other ethnic groups, and that most of African ethnics have the highest proportion of
derived allele in rang of minor allele frequency bin (0.0-0.1) (Figure 4.16), indicating that mutation
occurred in rare variants within gene-associated to HIV can play critical role in host HIV variation.
Figure 4.16: The distribution of the minor allele frequency categorised into 6 bins
(0− 0.05, > 0.05− 0.1, > 0.1− 0.2, > 0.2− 0.3, > 0.3− 0.4, > 0.4− 0.5) with respect to each
ethnic group regarding Actionable Genes.
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Figure 4.17: The distribution of the minor allele frequency categorised into 6 bins
(0− 0.05, > 0.05− 0.1, > 0.1− 0.2, > 0.2− 0.3, > 0.3− 0.4, > 0.4− 0.5) with respect to each
ethnic group regarding HIV genes.
Figure 4.18: The distribution of the minor allele frequency categorised into 6 bins
(0− 0.05, > 0.05− 0.1, > 0.1− 0.2, > 0.2− 0.3, > 0.3− 0.4, > 0.4− 0.5) with respect to each
ethnic group regarding Malaria genes.
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Figure 4.19: The distribution of the minor allele frequency categorised into 6 bins
(0− 0.05, > 0.05− 0.1, > 0.1− 0.2, > 0.2− 0.3, > 0.3− 0.4, > 0.4− 0.5) with respect to each
ethnic group regarding Sickle cells diseases genes.
Figure 4.20: The distribution of the minor allele frequency categorised into 6 bins
(0− 0.05, > 0.05− 0.1, > 0.1− 0.2, > 0.2− 0.3, > 0.3− 0.4, > 0.4− 0.5) with respect to each
ethnic group regarding Tuberculosis genes.
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To obtained gene-specific derived allele, derived allele frequencies were aggregated for all SNPs
associated to each of these disease-specific genes (see Materials and Methods section). We observe
consistent high ACG gene-specific derive allele in Latin America and most of Afro-Asiatic ethnic groups
following most of European related ethnic groups (Figure 4.21), while a low ACG gene-specific derive
allele are observed in most of African ethnic groups. One can expect actionable gene to have high
proportion of derived allele, however this is not the case for most of African ethnic group, indicating
that current ACG genes were primarily tailored for non-African.
For all 4 African burden diseases include HIV (Figure 4.22), TB (Figure 4.25), Malaria (Figure
4.23) and Sickle-Cell Diseases (Figure 4.24), we observe that Latin America and most of Afro-Asiatic,





















































































































































































































































































































































































































Figure 4.25: TB Gene-specific proportion of derived allele among 20 world-wide ethnic groups.
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4.3.5 Genetic Diversity: Observed and Expected Heterozygosity
Gene diversity consists of two elements including the abundance (or evenness) of the alleles and the
number of alleles. The abundance (or evenness) of the alleles and the number of alleles would increase
the expected heterozygosity. If an ethnic group or population consists of an excess of homozygotes for
different alleles this leads to a low observed heterozygosity. In Figure 4.26, we observe that African
and African diaspora ethnic groups, particularly Bantu and Khoesan ethnic have highest gene diversity
in HIV, TB, Malaria, Sickle-Cell disease and ACG associated variants. This result supports highest
genetic diversity found in individuals and communities across the African continent, and that the use
of personalised medicine will be beneficial both to the continent and worldwide.
Figure 4.26: Plot Expected heterozygosity as a function of observed
heterozygosity per genes of specific diseases within each population.
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4.4 Discussion and Chapter Summary
This chapter intended to provide a broad assessment of possible actionability of variants known to be
associated to top four burden African diseases and a list of actionable genes from American College of
Medical Genetics and Genomics (ACMG) using Whole Genome Sequence data of 20 world-wide ethnic
groups from a combined data of the African Genome Variation and 1000 Genome Project. We focused
on list of genes related to four of Africa’s burden diseases (TB, Malaria, SCD and HIV/AIDS) and
most importantly, actionable genes (ACG) proposed by of ACMG. We obtained 77, 50, 75, 460 and 114
genes known to associate with Tuberculosis, Malaria, Sickle Cell disease, HIV and ACG, respectively.
We examine the distribution of pathogenic mutation based on these selected known disease-genes across
20 world-wide population ethic groups.
1. HIV/TB: Our results indicated that African ethnic groups include Bantu and Latin American
and Afro-Asiatic have the highest proportion of pathogenic variants based on 483 HIV-specific
genes. From 77 TB-specific genes, we observed that Latin American and Afro Asiatic ethnic
groups have the highest proportion of pathogenic variants, important among all African and
African diaspora ethnic groups, only Khoesan has high proportion of pathogenic variant within
TB-specific genes.
2. Malaria and Sickle-Cell : Our result indicate absent of pathogenic variants in most of
European related ethnic groups and low proportion of pathogenic variants across all Malaria-
specific genes in Bantu and Afro-Asiatic and Latin American ethnic groups, except for Toll-like
receptor 9 (TLR9 ) , FREM3, IL4, ICAM-1 and Nitric oxide synthase 1 (neuronal) that Bantu
ethnic groups and Latin America have high proportion of pathogenic. Furthermore, Bantu,
Afro-Asiatic and Latin America have similar low proportion of pathogenic variants in most of
Sickle-Cell disease-specific genes, except in MYO7B, CPS1, COL6A3, MTRR, SLC22A5, ABCC1,
and RPL3L.
3. ACG : Our present result showed a considerable high proportion of pathogenic variants within
ACG-specific genes from non-African ethnic groups include Latin America, Afro-Asiatic European
related ethnic groups compare to most of African related ethnic groups. This result justifies and
indicates that the actionability of these ACG genes may have differing effects on world-wide
ethnic groups.
We leveraged the dbSNP database to extract SNPs associated with these genes per diseases. The
obtained SNPs per disease were thus extracted from the whole phased data contained 4,932 samples of
these 20 ethnic groups; yield 5 disease-specific phased haplotypes data sets. From these phased haplo-
types data, we conducted disease gene-specific population structure, we examined the distribution and
relationship of derived and minor allele frequency and estimate the expected and observed heterozygosity.
Our result suggests significant genetic variation among all non-European ethnic groups, mostly
African and African diaspora ethnic groups, while all European ethnic groups are genetically and
consistently clustering together based on these diseases or actionable-specific variants. In addition,
our result indicates that African and African diaspora ethnic groups, particularly Bantu and Khoesan
ethnic have the highest gene diversity in HIV, TB, Malaria, Sickle-Cell disease and ACG associated
variants. This supports the highest genetic diversity found in individuals and communities across the
African continent, and that the use of personalised medicine will be beneficial both to the continent
and worldwide.
1. HIV/TB : Most African ethnics groups (Bantu and Khoisan) have highest HIV and TB gene-
specific frequency, indicating that HIV infection has high incidence or prevalence among African
ethnic groups compare to other ethnic groups. Our result identifies BTNL2,MOS, CDSN, USP18,
MCM8, OAS1, COG4, CCL3L1, HLA-G, HLA-E, STT3A, TMED2 and USP18 to have HIV
gene-specific in SNPs frequencies ranging between 5% to 15% and that African ethnic groups
have the highest. In addition, 33 genes have TB gene-specific in SNPs frequencies between
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5% to 20% of which all African ethnic groups have the highest frequencies. This suggests that
these genes may harbor common effect and contribution in TB/HIV among African ethnic
groups. Furthermore, HIV/TB gene-specific have high proportion of derived allele at low African
ethnic-specific minor allele frequency (0.0 to 0.1) and that these proportion derived allele vary
among African ethnic groups.
2. Malaria and Sickle-Cell : We identify five genes including GYPB, FCGR2A, IL13, and
FREM3 with Malaria gene-specific in SNPs frequencies ranging between 4% to 15%, while all
Sickle-Cell disease related genes have low gene-specific in SNPs frequencies ranging between
0.1% to 0.3% among all 20 ethnic groups, but all African and diaspora ethnic groups have the
highest in that range.
3. ACG : Our result indicates all ACG genes have gene-specific in SNP frequencies low than
0.4% in all ethnic groups. However, the gene-specific in SNP frequencies from most of African
ethnic groups are higher compare to those from non-African ethnic groups, supporting potential
effect and contribution of these actionable genes among world-wide ethnic groups. High ACG
gene-specific derive allele, was observed in Latin America and most of Afro-Asiatic ethnic groups
following most of European related ethnic groups, while a low ACG gene-specific derive allele
are observed in most of African ethnic groups.
Overall, the results in this chapter suggest that given the highest genetic diversity found in African
ethnics and African diaspora related ethnics at these four Africa burden diseases and current actionable
gene associated, (1) the use of personalised medicine will be beneficial both to the African continent
and worldwide; (2) enabling a recommendation for African-specific actionable list of genes will further
improve African and diaspora healthcare.
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Advances in sequencing technologies have facilitated the development of novel statistical genomics
approaches with applications ranging from clinical care to pharmaceutical industries. These have led to
an unprecedented increase in the computational complexity of downstream data analysis. An obstacle
to validating and bench-marking methods for genome analysis is that there are few reference data
sets available for which the “ground truth” about the mutational landscape of the sample genome
is known and fully validated. Furthermore, accuracy, effectiveness and performance assessments of
different analytical methods used to analyse next generation sequence data are important aspects of
medical population genetics.
In this project, we provide a broad discussion on DNA sequence simulation tools. Further, we have
described the process of DNA sequence simulation tools, and we have illustrated some example for
each tool representing different NGS platforms. Since, variant calling (VC) is an important aspect of
genomics studies as polymorphism information can be used to influence important clinical decisions,
the project has dissected and discussed 9 current state-of-the-art variant calling tools. In doing so, we
made use of NEAT-GenReads, to simulate a total of 100 DNA sequence samples of which every 50
samples mimicked the genetics background of the African and European population, respectively at
different coverage (high and low), respectively. We have evaluated the simulation outcomes to ensure
our result is not truncated or damaged. We have checked the quality of FastQ files by using FastQC
tool, checking golden BAM, VCF by using samtools features.
The tremendous development of Next-Generation sequencing has promoted the evolution of
personalised medicine. Such progress in NGS resulted in an enlargement of the downstream analysis
tools to handle such data. Such an example, many variant calling tools have been developed, which
raise the question of which tool one can choose when dealing with a complex and diverse genome
such as the African genome? To address this question, we compared nine variant calling tools include
VarScan2, SAMtools, GATK-HaplotypeCaller, SNVer, BCFtools, FreeBayers, Lofreq, PlatyPus and
VarDict) based on simulated data representing two population (African and European) at varying
coverage (high and low) as a total of 4 data sets. These tools were evaluated based on the sensitivity
and precision and most importantly, the F-score to measure the overall performance, low sensitivity
and precision result in low F-score.
The result of this evaluation suggests that Lofreq can currently be a great option in calling WGS
from African populations and VarDict can be considered for targeted sequence, particularly for African
data. Given huge amount of non-overlapped variants across the results from current VC tools and
differing number of variants discovered across these tools, it will be reasonable to consider multi variant
calling tools to allow cross validation of variants discovered. In the next chapter, we will use Lofreq to
call the variants on WGS of real populations.
Given the result the above evaluation, we have leveraged Whole Genome Sequence data of 20
world-wide ethnic groups from a combined data of the African Genome Variation and 1000 Genome
Project to provide a broad assessment of possible actionability of variants known to be associated to
top four burden African diseases (HIV/AIDS, Malaria, Tuberculosis (TB), and Non-communicable
diseases: such as Sickle cell disease) and a list of actionable genes from American College of Medical
Genetics and Genomics (ACMG).
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Our analysis focused on the obtained list of genes related to four of Africa’s burden diseases (TB,
Malaria, SCD and HIV/AIDS) and most importantly, actionable genes (ACG) proposed by of ACMG.
We obtained 77, 50, 75, 460 and 114 genes known to be associated to Tuberculosis, Malaria, Sickle Cell
disease, HIV and ACG, respectively. We examine the distribution of pathogenic mutation based on
these selected known disease-genes across 20 world-wide population ethic groups.
1. Our results indicated that African ethnic groups include Bantu and Latin American and Afro-
Asiatic have the highest proportion of pathogenic variants based on 460 HIV-specific genes. From
77 TB-specific genes, we observed that Latin American and Afro Asiatic ethnic groups have the
highest proportion of pathogenic variants, important among all African and African diaspora
ethnic groups, only Khoesan has high proportion of pathogenic variant within TB-specific genes.
2. Our result indicate absent of pathogenic variants in most of European related ethnic groups and
low proportion of pathogenic variants across all Malaria-specific genes in Bantu and Afro-Asiatic
and Latin American ethnic groups, except for Toll-like receptor 9 (TLR9 ) , FREM3, IL4, ICAM-1
and Nitric oxide synthase 1 (neuronal) that Bantu ethnic groups and Latin America have high
proportion of pathogenic. Furthermore, Bantu, Afro-Asiatic and Latin America have similar low
proportion of pathogenic variants in most of Sickle-Cell disease-specific genes, except in MYO7B,
CPS1, COL6A3, MTRR, SLC22A5, ABCC1, and RPL3L.
3. Our present result illustrated a considerable high proportion of pathogenic variants within ACG-
specific genes from non-African ethnic groups include Latin America, Afro-Asiatic European
related ethnic groups compare to most of African related ethnic groups. This result justifies and
indicates that the actionability of these ACG genes may have differing effects on world-wide
ethnic groups.
We leveraged the dbSNP database to extract SNPs associated with these genes per each of these
four Africa’s burden diseases (TB, Malaria, SCD and HIV/AIDS) and the set of actionable genes
(ACG). The obtained SNPs per disease were thus extracted from the whole phased data contained 4,932
samples of these 20 ethnic groups; yield 5 disease-specific phased haplotypes data sets. From these
phased haplotypes data sets, we independently conducted disease gene-specific population structure,
we examined the distribution and relationship of derived and minor allele frequency and estimate the
expected and observed heterozygosity.
Our result illustrated a significant genetic variation among all non-European ethnic groups mostly
but all European ethnic groups are genetically and consistently clustering together based on these
diseases or actionable-specific variants. In addition, our result indicates that African and African
diaspora ethnic groups, particularly Bantu and Khoesan ethnic have the highest gene diversity in
HIV, TB, Malaria, Sickle-Cell disease and ACG associated variants. This supports the highest genetic
diversity found in individuals and communities across the African continent, and that the use of
personalised medicine will be beneficial both to the continent and worldwide. Furthermore, our results
suggested the follows,
1. Most African ethnics groups (Bantu and Khoisan) had highest HIV and TB gene-specific
frequency, indicating that HIV infection has high incidence or prevalence among African ethnic
groups compare to other ethnic groups. Our result identified BTNL2,MOS, CDSN, USP18,
MCM8, OAS1, COG4, CCL3L1, HLA-G, HLA-E, STT3A, TMED2 and USP18 to have HIV
gene-specific in SNPs frequencies ranging between 5% to 15% and that African ethnic groups
had the highest. In addition, 33 genes had TB gene-specific in SNPs frequencies between 5%
to 20% of which all African ethnic groups had the highest frequencies. This findings suggests
that these genes may harbor common effect and contribution in TB/HIV among African ethnic
groups. Furthermore, HIV/TB gene-specific have high proportion of derived allele at low African
ethnic-specific minor allele frequency (0.0 to 0.1) and that these proportion derived allele vary
among African ethnic groups.
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2. We identified five genes including GYPB, FCGR2A, IL13, and FREM3 with Malaria gene-specific
in SNPs frequencies ranging between 4% to 15%, while all Sickle-Cell disease related genes have
low gene-specific in SNPs frequencies ranging between 0.1% to 0.3% among all 20 ethnic groups,
but all African and diaspora ethnic groups have the highest in that range.
3. Our result illustrated that all ACG genes have gene-specific in SNP frequencies low than 0.4% in
all ethnic groups. However, the gene-specific in SNP frequencies from most of African ethnic
groups are higher compare to those from non-African ethnic groups, supporting potential effect
and contribution of these actionable genes among world-wide ethnic groups. High ACG gene-
specific derive allele, was observed in Latin America and most of Afro-Asiatic ethnic groups
following most of European related ethnic groups, while a low ACG gene-specific derive allele
are observed in most of African ethnic groups.
Overall, given the observed highest genetic diversity found in African ethnics and African diaspora
related ethnics at these four Africa burden diseases and current actionable gene associated, our results
support (1) the use of personalised medicine as beneficial to both African continent and worldwide; (2)
a recommendation for African-specific actionable list of genes to further improve African and diaspora
healthcare; (3) future efforts are needed to accurately identify the secondary findings, by improving the
downstream analysis such variant calling methods when using African data and developing an African






Table A.1: Lists of gene-disease pairs of HIV/AIDS, Malaria, Tuberculosis (TB),
Sickle cell disease and Actionable genes.
Genes Associated with HIV/AIDS
A4GALT, ATG16L2, CAV2, CTDP1, DNAL1, FASLG, HCG22, IL10, MED14, NUP153, PRKX, SEC14L1,
TLR8, TNPO3ABCB1, ATG7, CCDC134, CTLA4, DOK6, FBXO18, HCP5, IL10RA, MED28, NUP155,
PSME2, SERPINA1, TLR9, TNS1ABO, ATP6V0A1, CCL11, CUL5, DPCR1, FBXO21, HCP5P2, IL12A,
MED4, NUP160, PSORS1C1, SESTD1, TM9SF2, TNXB,ACTR3BP6, BAHD1, CCL2, CX3CR1, DPM1,
FBXW11, HCRTR2, IL12B, MED6, NUP85, PSORS1C3, SFT2D1, TMED2, TOMM70AADAM10, BCL9,
CCL5, CXCL12, DYRK1A, FCGR2A, HEATR1, IL13, MED7, ODZ4, PURA, SIP1, TMEFF2, TOR2A,
ADAM18, BOD1P, CCNT1, CXCR4, DYSF, FGD6, HGS, IL2, MEPE, OTUD3, RAB1B, SLC35F4,
TMEM132C, TRAPPC1,ADH5P4, BTNL2, CCR2, CXCR6,ECR777, FHL3, HIBCH, IL2RA, MGAT1,
PABPC1P2, RAB28, SLC46A1, TMEM163, C10orf71, CCR5, CYP7B1, EDNRA, FKBP1AP4, HIP1R, IL32,
MICA, PANK1, RAB2A, SLCO5A1, TMEM181, TRIM10,AGAP2, C1ORF103, CD209, DAB1, EFEMP1,
FLII, HIST1H3B, IL4, MID1IP1, PC, RAB6A, SNN, TMEM182, TRIM55, AGBL5, C21orf96, CD4, DARC,
EFHC2, FNTA, IL4R, MKI67, PCDH11X, RAB6B, SOX11, TMTC1, TRIM58, AKT1, C3ORF56, CDSN,
DDEF2, EGF, FOXN3, HLA, IL6, MKRN2, PDE7A, RAB6C, SP110, TNF, TRMT5, ALKBH8, C6ORF1,
CHORDC1, DDOST, EGFR, FUT2, HLA-A, INTS7, MMADHC, PDIA6, RABEPK, SPAST, ZNF436,
TUBAL3 ANKRD30A, C6orf106, chrna3, DDX10, EIF2C3, GABARAP, HLA-B, IQUB, MND1, PHF12,
RANBP1, SPATS2L, ZNF512B, UBQLN4, ANKRD43, C6orf48, chrna5, DDX3X, EIF3H, HLA-B, IRF4,
MOS, PHF3, RANBP2, SPCS3, ZNF536, UBQLN4P1, ANKRD6, C7orf58, DX53, EPHA5, GAPVD1,
HLA-C, ITPKA, MPHOSPH6, PIGH, RAP1B, SPTAN1, ZNF720, ANKRD9, CACNG1, CLN3, DDX55,
EPS8, GBAS, HLA-DPA1, JAK1, MR1, PIGK, RAPGEF1, ZNF785, USP26, ANXA1, CADM1, CLNS1A,
DEFB1, ERCC3, GCK, HLA-DQA1, JHDM1D, PIGY,RAPGEF2, SSB, ZNF791, USP6, AOAH, CAPN6,
CMTM8, DEPDC5, ERI2, GLRX3, KAT2A,NBEA, PIP5K1C, RELA, ST3GAL5, ZNF804A, VANGL2,
AP2M1, CARD16, COG2, DHX33, ERP27, GLTSCR1, HLA-E, KBTBD7, NCOR2, PKD1L2, RGP1,
STAC2, ZNF804A, VPRBP, APOBEC3G, LNX2,COG3, DIMT1L, ETF1, GNPDA2, HLA-G, KCNIP3,
NDUFB7, PLEKHA3, RIMS4, STARD3NL, HLA-B57,VPS53, ARF1, LOC375190, COG4, DMXL1, ETHE1,
GOLPH3, HMGXB3, KCNK9, NEDD9, PLOD3, RNF170, STT3A, CXCL11, VWC2L, ARGLU1, LPL,
CRIPAK, DNAJB1, EVI5L, GOSR2, HNRNPF, KDM4D, NF2, PM20D1, RNF212, STX5, IFI44, WASF5P,
ARHGAP32, LRRC8D, CRTC2, LCP2, EXOSC3, GPC5, HTATSF1, KEL, NGLY1, PNRC1, RNF26,
SUV420H1, IFI6, WDR27,ARHGEF12, LSM3, CRTC3, LEFTY1, EXOSC5, GPR156, HUWE1, KIAA1012,
NIPSNAP3B, POLR3A, RPL13AP15, TAOK1, IFIT3, WDTC1, ARHGEF19, LY6D, CSPP1, RPL28P3,
FA2H, GRIN2A, IDH1, KIF3C, NLRP1, POLR3F, RPL15P15, TAP2, RSAD2, WNK1, ARPC1A, LYPD4,
TFE3, RPL32P3, FAM174B, GRM5,IER3, KIR3DL1, NMT1, POU1F1, RPL21P119, TCEB3, CIG-5,
WNT1, ASXL2, MAD2L1, THAP3, RPL4P5, FAM200B, GRTP1, IFNAR1, KLHDC2, NOS3, PP2672,
RPL21P126, TFAP4, ANKRD22, XKR4, ATG12, MAP4, THOC2, RPTN, FAM5B, H3F3A, IFNG, KLHL1,
NOTCH4, PPIB, RPL21P75, TFDP2, CXCL9, YTHDC2, MCM8, MBL2, THRAP3P1, RRAGB, ZNF12,
HB1, IFNGR1, KTN1, NR0B2, PPP2R2A, STAT1, CMPK2, CXCL10,ZBTB2, MDN1, MBL2, TIAM2,
RSL1D1, ZNF182, LAPTM5, NUP107, PPP3CC, GBP1, XAF1, USP18, ZDHHC19, TIMM8A, RTN2,
ZNF354A, LARS, NUP133, PRDM14, ISG43, BIRC4BP, OASL, ZFP90, TLR7, RUSC2, ZNF385D, PRDM7,
OAS1, OAS2, SAMD5, PRF1, GZMH, HLA-B, SCFD1, PRKG2, NKG7, SDC1 TRIB1, AE01, GALNT14,
CLDND1, UGT1A12P, SPTBN1, NAV2, HLA-DQB1, IGHMBP2
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CHROM POS ID REF ALT QUAL FILTER INFO(ADP;WT;HET;HOM;NC)
FORMAT (GT:GQ:SDP:DP:RD:AD:FREQ:PVAL:RBQ:ABQ:RDF:RDR:ADF:ADR)
Samtools










#CHROM POS ID REF ALT QUAL FILTER INFO(DP;AF;NP;PV)
FORMAT(AC:DP)
Bcftools
CHROM POS ID REF ALT QUAL FILTER INFO(DP;VDB;SGB;RPB;MQB;MQSB;
BQB;MQ0F;ICB;HOB;AC;AN;DP;MQ) FORMAT(GT:PL)
FreeBayers






CHROM POS ID REF ALT QUAL FILTER INFO(DP;AF;SB;DP4)
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(2018). A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-
Ethnic Genotyping Array. Frontiers in genetics , 9 , 678. doi: 10.3389/fgene.2018.00678
Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010). MutationTaster evaluates
disease-causing potential of sequence alterations. Nature Methods , 7 (8), 575–576. Retrieved
from https://doi.org/10.1038/nmeth0810-575 doi: 10.1038/nmeth0810-575
Shcherbina, A. (2014). FASTQSim: Platform-independent data characterization and in silico
read generation for NGS datasets. BMC Research Notes, 7 (1), 1–12. doi: 10.1186/
1756-0500-7-533
Shen, T., de Stadt, S. H., Yeat, N. C., & Lin, J. C.-H. (2015). Clinical applications of
next generation sequencing in cancer: from panels, to exomes, to genomes. Frontiers
in Genetics , 6 , 215. Retrieved from https://www.frontiersin.org/article/10.3389/
fgene.2015.00215 doi: 10.3389/fgene.2015.00215
Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin,
K. (2001, jan). dbSNP: the NCBI database of genetic variation. Nucleic acids research,
29 (1), 308–311. doi: 10.1093/nar/29.1.308
Shihab, H. A., Gough, J., Cooper, D. N., Day, I. N. M., & Gaunt, T. R. (2013, jun). Predicting
the functional consequences of cancer-associated amino acid substitutions. Bioinformatics
(Oxford, England), 29 (12), 1504–1510. doi: 10.1093/bioinformatics/btt182
Sirugo, G., Hennig, B. J., Adeyemo, A. A., Matimba, A., Newport, M. J., Ibrahim, M. E.,
. . . Williams, S. M. (2008). Erratum: Genetic studies of African populations: An
overview on disease susceptibility and response to vaccines and therapeutics (Human
Genetic (2008) vol. 123 (557-598) 10.1007/s00439-008-0511-y) (Vol. 124) (No. 2). doi:
10.1007/s00439-008-0534-4
Søborg, C., Bengaard, A., Range, N., Malenganisho, W., Friis, H., Magnussen, P., . . . Garred,
P. (2007). Influence of candidate susceptibility genes on tuberculosis in a high endemic
region. , 44 , 2213–2220. doi: 10.1016/j.molimm.2006.11.002
Spencer, D. H., Tyagi, M., Vallania, F., Bredemeyer, A. J., Pfeifer, J. D., Mitra, R. D., &
Duncavage, E. J. (2014). Performance of common analysis methods for detecting low-
frequency single nucleotide variants in targeted next-generation sequence data. Journal
of Molecular Diagnostics, 16 (1), 75–88. Retrieved from http://dx.doi.org/10.1016/
j.jmoldx.2013.09.003 doi: 10.1016/j.jmoldx.2013.09.003
Spinella, J. F., Mehanna, P., Vidal, R., Saillour, V., Cassart, P., Richer, C., . . . Sinnett, D.
(2016). SNooPer: A machine learning-based method for somatic variant identification
from low-pass next-generation sequencing. BMC Genomics , 17 (1), 1–11. Retrieved from
http://dx.doi.org/10.1186/s12864-016-3281-2 doi: 10.1186/s12864-016-3281-2
Stead, L. F., Sutton, K. M., Taylor, G. R., Quirke, P., & Rabbitts, P. (2013). Accurately
identifying low-allelic fraction variants in single samples with next-generation sequencing:
Applications in tumor subclone resolution. Human Mutation, 34 (10), 1432–1438. doi:
10.1002/humu.22365
Stephens, Z. D., Hudson, M. E., Mainzer, L. S., Taschuk, M., Weber, M. R., & Iyer, R. K. (2016).
Simulating next-generation sequencing datasets from empirical mutation and sequencing
models. PLoS ONE , 11 (11), 1–18. doi: 10.1371/journal.pone.0167047
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